TBPN - Crémieux & Kian on Nucleus Genomics, Michael Kratsios on Genesis, Nvidia Responds to TPU Progress | Kian Sadeghi, Joe Weisenthal, Sebastian Siemiatkowski, David Faugno, Keller Rinaudo, Royce Branning
Episode Date: November 25, 2025(01:53) - 𝕏 Timeline Reactions (13:14) - Nvidia Responds to TPU Sales (22:15) - Trump Launches Genesis (25:40) - Trait-Based Embryo Selection Ethics Breakdown (45:17) - Cremieux, a cri...tic of Nucleus Genomics' embryo selection product, discusses the company's misleading claims about their technology's capabilities, particularly in predicting complex traits like intelligence and appearance. He highlights the scientific implausibility of their assertions, noting that their methods cannot reliably predict such traits, and expresses concern over the ethical implications of offering parents a false sense of control over their future children's genetics. Cremieux also points out the potential harm in promoting a product that lacks scientific validation, emphasizing the need for transparency and accuracy in genetic testing services. (01:05:01) - Kian Sadeghi, founder and CEO of Nucleus, a company specializing in consumer genetic testing and analysis, discusses the transparency and accessibility of Nucleus's scientific models, emphasizing that their science is public and available for independent evaluation. He addresses concerns about the authenticity of customer reviews, explaining that due to HIPAA regulations, real patient names and images cannot be disclosed, and acknowledges the need to update their website to clarify the use of anonymized information. Sadeghi also highlights the evolving nature of genetic models, noting that updates are part of their commitment to providing accurate and up-to-date information to patients. (01:28:58) - Joe Weisenthal, born September 2, 1980, in Detroit, Michigan, is an American journalist and television presenter, currently serving as the executive editor of news for Bloomberg's digital brands and co-host of the "Odd Lots" podcast. In the conversation, he discusses the prolonged timeline before AI and robotics significantly impact sectors like elder care, referencing Honda's Asimo robot's initial promise to assist the elderly. He also addresses the shift in tech financing from venture capital to substantial debt, highlighting concerns over managing this debt and the implications of credit default swaps on major companies like Oracle. Additionally, Weisenthal critiques Nvidia's public responses to competitors, suggesting that confident companies typically avoid commenting on rivals, and reflects on Nvidia's rapid ascent from a successful chipmaker to one of the world's largest companies. (01:59:49) - Michael Kratsios, the 13th Director of the White House Office of Science and Technology Policy, discusses the Genesis Mission, a national initiative launched by President Trump to accelerate scientific discovery through artificial intelligence. He emphasizes the collaboration between national laboratories, universities, and tech companies to create a centralized digital platform that leverages federal scientific datasets, aiming to automate experiment design and significantly shorten discovery timelines. (02:26:28) - Sebastian Siemiatkowski, co-founder and CEO of Klarna, discusses the company's launch of KlarnaUSD, a U.S. dollar-backed stablecoin, marking a significant shift from his previous skepticism toward cryptocurrencies. He highlights that KlarnaUSD aims to reduce costs and increase efficiency in cross-border payments by leveraging the Tempo blockchain developed by Stripe and Paradigm. Siemiatkowski emphasizes that this initiative reflects Klarna's commitment to innovation and its ambition to challenge traditional payment networks by offering faster and more affordable services to consumers and merchants. (02:38:09) - David Faugno, CEO of 1Password, discusses the company's growth to over $400 million in annual recurring revenue, with nearly 80% of business coming from enterprise customers. He highlights 1Password's initiatives in AI integration, including partnerships with Perplexity's Comet browser and OpenAI's ChatGPT Atlas, to enhance secure usage of AI tools. Faugno also emphasizes the importance of credential hygiene in the face of increasing security threats and shares personal insights into his preference for fly fishing in Utah and Montana. (02:50:59) - Keller Rinaudo, co-founder and CEO of Zipline, announced a $150 million contract with the U.S. State Department to expand Zipline's autonomous drone delivery network across Africa, aiming to serve over 15,000 health facilities and reach an additional 130 million people. He highlighted the shift towards "Commercial Diplomacy," emphasizing partnerships that foster trade and technological collaboration rather than traditional aid. Rinaudo also discussed Zipline's rapid growth in the U.S., noting record-breaking delivery volumes and the transformative impact of their services on customer behavior and local economies. (03:08:11) - Royce Branning, co-founder and CEO of Clearspace, discusses the company's mission to help individuals reduce screen time by providing tools that enhance intentionality in technology use. He highlights the asymmetry in the battle for attention online and emphasizes equipping consumers with the ability to steer their focus and protect their family's attention. Branning also introduces Clearspace's new screen time agents that operate at the network layer, offering comprehensive visibility and control over device usage across all platforms. (03:19:18) - 𝕏 Timeline Reactions TBPN.com is made possible by: Ramp - https://ramp.comFigma - https://figma.comVanta - https://vanta.comLinear - https://linear.appEight Sleep - https://eightsleep.com/tbpnWander - https://wander.com/tbpnPublic - https://public.comAdQuick - https://adquick.comBezel - https://getbezel.com Numeral - https://www.numeralhq.comPolymarket - https://polymarket.comAttio - https://attio.com/tbpnFin - https://fin.ai/tbpnGraphite - https://graphite.devRestream - https://restream.ioProfound - https://tryprofound.comJulius AI - https://julius.aiturbopuffer - https://turbopuffer.comfal - https://fal.aiPrivy - https://www.privy.ioCognition - https://cognition.aiGemini - https://gemini.google.comFollow TBPN: https://TBPN.comhttps://x.com/tbpnhttps://open.spotify.com/show/2L6WMqY3GUPCGBD0dX6p00?si=674252d53acf4231https://podcasts.apple.com/us/podcast/technology-brothers/id1772360235https://www.youtube.com/@TBPNLive
Transcript
Discussion (0)
You're watching TBPN.
Today is Tuesday, November 25th, 2025.
We are live from the TBPN Ultramome,
the Temple of Technology, the Fortress of Finance,
the capital of capital.
We had a fan, yesterday was Anthropic, Claude 4.5 day.
We had a lot of fun talking to Shulte about that.
You should go check it out.
We wrote a little write-up.
I collaborated with Brandon and Tyler
to kind of give our thoughts on the state of the AI
race with regard to open AI and anthropic and what makes anthropic special. The things that stuck
out to me, I mean, the thing that went viral was just the fact that apparently Dario goes around
Slack and writes essays every single day. And everyone was like, give me the essays, turn it into a book,
paging striped press. We got to get striped press to turn into a book. Yeah, and I mean,
well, that, but I was also thinking of potentially a risk vector for them being like the
the dario files
a disgruntled employee
that saves them all
and then leaks them all.
I imagine.
Because he, even when he's on Mike,
he's known to say some things
that he,
uh, at times,
uh, sort of, uh,
people, people, I feel like people take him out of,
out of, uh, out of context a lot.
Like, like, he will say,
he'll say, he's kind of the final boss.
If this doesn't, yeah, if this doesn't go well,
we could lose 50% of white collar work or,
entry-level white-collar work, and people will be like,
Anthropic state admission is to destroy jobs.
Take your father's job.
Yeah, yeah, it's rough.
But, uh, ramp, time is money, save both.
Easy use corporate cards, bill payments, accounting, and a whole lot more, all in one place.
Timeline was in turmoil over the weekend and yesterday.
We covered a little bit about the nucleus, uh, dust up on the timeline.
Cremew will be coming on the show at 1145.
And then Kian, the CEO of Nucleus, will be coming on the show at noon.
So we will kind of have both sides.
Then we have Joe Wisenthal joining from Bloomberg.
And then we have, who else do we have today?
Cratios.
Crancius is coming on to break down Project Genesis, which we're very excited about.
Anyway, let's run through what other news stories.
were at the top of the timeline while we pulled those up let me tell you about
restream one live stream 30 plus destinations if you want to multi stream go to
restream.com oh yes the biggest news in tech in AI is that the
Ilya Sutskiver Dwar Keshe Patel podcast has dropped do we have hit the time
the do we have the opening clip because the opening clip is is iconic it's
it's it's very funny it's like it's a bit of a hot mic moment
for Ilya and I think we should
pull it up and play it
because it has a fascinating
just insight into it feels
very like oh this is where this is the real
Ilya he's not he's not even thinking
that he's on camera and he gives his
real
his real feelings so let's let's play this from the
very start crazy that all of this
is real
yeah don't you think so
like all this AI stuff
and all this big area yeah that it's
like isn't it
straight out of science fiction.
Yeah. Another thing that's crazy is like how normal the slow takeoff feels.
The idea that we'd be investing one percent of GDP in AI.
It hasn't even set up the cameras yet.
There's a bigger deal.
You know, where right now it just feels like...
And we get used to things pretty fast, turns out, yeah.
But also it's kind of like it's abstract.
Like, what does it mean?
What it means that you see it in the news.
Yeah.
That such and such company announced such and such dollar amount.
Right.
That's all you see.
Right.
it's not really felt in any other way so far.
Should we actually begin here?
I think this is an interesting discussion.
Sure.
It's one of the greatest podcast intro from the average point of view.
So good.
Really good.
So good.
Anyway, we're not going to watch the whole show.
That's going to be a new meta.
Yes.
Yes.
I mean, you can't fake that.
It's amazing.
Also, it's just funny because it's effectively getting caught on a hot mic.
But I was joking.
I was like, of all the things that you could say on the hot mic before you
sit down. Oh, okay, we're actually recording. His is just completely reaffirming everything we know
about Ilius at square. It's just completely the same. Like, okay, he is a true believer. It's not like
he was sitting down and being like, like, Norcash. Like, we got to go on my private plane. I just
sold so much secondary. It's crazy what's going on with this stuff. Like, if people really think
this AI thing's going to pan out, I'm making billions of dollars. I'm bashing out. I'm, I don't
believe any of this stuff is real.
No, he wasn't caught on a hot mic like that.
His hot mic moment is like, wow, it's exactly like science fiction.
Everything is all real.
It's all real, yeah, which is just iconic.
Well, you can go and listen to that in the Dorcasch Patel RSS feed and on the YouTube channel and on X.
He put the full thing up.
It's 95 minutes long.
Tyler, did you have any other takeaways from your speed run?
You're listening to it at 5X, right?
Well, on X you can only do up to 2X.
I was on that, so I still have like 10 minutes left.
But yeah, a bunch of good stuff in here.
Does he pop the scaling bubble?
Does he give a bearish take about AI at any point?
While you're thinking about that, let me tell you about Gemini 3 Pro.
Google's most intelligent model yet.
State of the art reasoning, next level vibe coding, and deep multimodal understanding.
Continue.
So I wouldn't say he's like anti-scaling, but he does kind of give this interesting take,
which he basically says that like now AI companies, like there's two few.
ideas for the amount of companies and for the scale that we're at where he basically
like you can think of AI progress as being in these kind of distinct ages right so
he says 2012 to 2020 was like the age of research where you're trying all these like
different ideas and the scale of things is very small right like to train the
original AlexNet was like two GPUs to do the original transformer was like
eight maybe 64 but like you know very small amount of GPUs
And then once we kind of figured out that Transformers work,
we entered this age of scaling.
And that's basically from 2020 to 2025.
And now we're basically at this point where, like, yes, you can keep scaling,
and models will get better.
But even if you scale 100x, like, are we really going to get super intelligence?
Like, it'll get better on the benchmarks, and they'll become more useful.
But it's not like this, he doesn't think that just raw scaling alone is basically what's going to bring us there.
I mean, this has been, I could by a lot of people.
This was, I think, Carpathie said this
where we still need a couple different kind of paradigms
for this to work.
And even he's, like, this is even kind of what Shulte said yesterday,
which is like, pre-training, it's not dead,
but it's like, the reason that Opus 4.5 was better
is not just because they scaled pre-training.
It's scaling generally.
But even then, like, the scaling,
has gone from pre-training, and now it's RL.
Yeah.
And so we basically, we need to find another paradigm.
And the way you do that is just doing, like, research.
And so he talks about SSI as basically being this, like,
all they do is research.
Return to research.
Yeah, it's small kind of training runs.
Even though, you know, they only raise $3 billion,
which is, like, small compared to other research institutions,
the fact that they're basically putting it all on these kind of,
I mean, I don't know if they're moonshots,
but they're these small training runs.
where they're doing experiments.
And then they're going to scale it up eventually.
But they're not just basically trying to win the AI race
by just scaling up and doing the same thing as everyone else.
Yeah, yeah.
They're trying to find a new,
a way to actually bend the scaling curve,
find a new scaling law,
or find a new technology that they can scale against.
I was thinking about Ilya's talk at Nureps last year.
He pulls up this chart of the relationship
between the mammal's mass and the brain volume, and it's a pretty linear graph.
And so, like, the elephant is a lot bigger than the mouse.
And so it has a proportionally larger brain to its body volume.
And it's this perfect, it's this perfect linear curve.
I should, I should just try and figure it out.
If I can maybe text it in, I took a picture of it.
Because it's a very, it's a very cool chart.
Here it is.
Where do I send this?
Is the timeline?
Let me see.
Ship it.
Share.
Let me see.
Timeline.
Sorry.
Boom.
So basically the, the mammals have this very clear, linear trend, but then the non-human primates
are a little bit higher up on the chart, and they're just doing a little bit better.
But then hominids, the actual humans, have a different,
there's a very distinctly different curve.
And so there's this interesting, like, it was making me think, like,
maybe that's what we're supposed to see when we think about, yeah, this, this.
It's like, it's like, when we say, like, straight lines on log graphs,
when we say we are seeing scaling happen with the current architectures,
which line are we scaling against?
Are we actually scaling on the human curve?
or are we waiting for divergence from that current scaling law?
Yeah, he has this good quote where scaling has taken all the air out of the room, right?
Where like basically, like we have more than enough compute to try these like different ideas.
But they're just all going straight into training the next big model using the next paradigm.
And maybe it's slightly different, right?
You have a different way of doing RL or whatever.
But it's still fundamentally the same thing, right?
And he talks about maybe continual learning is,
really the better approach, right? We've been in this era of like having a pre-training thing for so long
that we think of like AI as like, you train this thing and then you release it and it's like done.
And RL's like a little bit different now because there's this idea of post-training and you can
kind of integrate different things. I also thought the interesting thing was with pre-training,
you use the whole internet so you don't have to decide anything. You're just applying this algorithm
to just all the data, all the compute and there's no decisions. But then with RL, you have to decide,
okay, we're putting in these math equations
and we're maybe not putting in something else
because we're actually creating the data
and it's not just this simple thing.
This is maybe why we see these kind of like models
that are super well.
They do super well in e-vails, but not so much.
Yeah, somebody overfitting.
And the reason is because the data that we choose
is not the correct data.
Yeah.
Because researchers are basically being reward hacked
maybe into like just solving for benchmarks.
Yeah.
It's interesting.
it's interesting to hear this, like, the conclusion is we need another breakthrough and then
simultaneously consensus be, like, but like we're definitely going to get that breakthrough in like
the next decade. It's like, it's hard, like these breakthroughs, it's hard to predict. I feel like it's hard to
predict. I feel like it echoes a lot of even what Mike Newpe has been saying. We need new idea.
Yeah, totally.
Yeah, totally. Saying this for, for months. But it's way, it's way hard to predict the rate at which
breakthroughs will arrive, as opposed to, like, you can actually chart out, okay, the formation
of capital, the time it takes to build a data center, how long it takes to, you know, manufacture
a bunch of GPUs, rack them, run the training round.
Like, that's much more predictable than like human came up with new algorithm.
Like, that's sort of random.
And he brings us up as the reason why you see companies doing this, because it's just,
if you're raising money, it's so much easier to justify the raise by saying, we're going to buy this
data center and we're going to do this training run.
It's going to cost exactly no as much.
going to monetize this way.
Yeah, and then the model will be this good,
and then we can use it to monetize this way.
Totally.
Where if you're just saying, like, oh, yeah,
we're just going to pay a bunch of, like, really smart researchers
to do a bunch of research,
and then they'll figure something out.
Yeah, like, you can't really be.
Yeah, in some ways, it feels like SSI is set up
for, like, somewhat of a mini AI winter
or, like, at least riding the hype cycle down.
Yeah.
Because it doesn't sound like he's sitting there being like,
we raise $3 billion and we're spending it in the next 12 months.
It's like...
2.9 was that.
No, not, not...
No, no, no, no.
The point is not.
It's like equity.
It's just sitting there.
It's like he can clearly pull back.
I'm going to give each researcher,
all these different teams,
like shots on gold.
No, I love it.
We're going to keep taking those shots until obviously he'd be able to raise like
another $10 billion whenever he wants,
especially if he has like a key breakthrough insight and they can be first to scale that.
Yeah.
Well, let me tell you about cognition.
They make Devin, the AI software engineer,
crush your backlog with your personal AI engineering team.
NVIDIA has posted.
They hit the timeline.
They hit the timeline. Break this down from you, Jory.
They said, we're delighted by Google's success.
They've made great advances in AI, and we continue to supply to Google.
NVIDIA is a generation ahead of the industry.
It's the only platform that runs every AI model and does it everywhere.
Computing is done.
NVIDIA offers greater performance,
versatility and fungibility than A6, which are
designed for specific AI frameworks or functions.
That is a crazy thing to post.
Crazy, crazy, crazy thing to post.
Sometimes we get stuff from Indiana.
I don't know, boys, but having the largest company in the world sending tweets to defend
their main product is not very reassuring.
Yeah, it's just an odd, I feel like this would be so much better delivered.
I actually don't have that much of a problem with the actual text here.
I just think this should be delivered by Jensen with some nuance.
in a conversational setting, it just hits a lot different when this is in at exactly 9 a.m.,
like clearly scheduled, clearly typed out in a document, you know, it's like, it feels like
a press release, which is just an odd thing when it should be, you know, there should be an
answer to a question which, uh, someone, Bobby Cosmic in the chat was saying like, oh,
the mainstream media is just now picking up on the Gemini three story. And there's articles
in the Wall Street Journal and other places saying like, oh, maybe Google's back.
Like, you know, buy Google.
Like, it's very exciting.
And so, Nvidia feels the need to respond to that.
But it's a lot different when it's actually a response instead of just like, we're putting
out a press release.
Like, who knows why?
Yeah.
As opposed to like Jensen saying like, well, since you asked, you know, talk show host or
news anchor or whoever he's top podcast host, whoever he's talking to, Dwarkash, you know.
Whoever he's talking to, maybe us, we'd love to have them.
I can ask him that question.
He can defend this here.
Yeah.
Well, the timing seems important because they are coming under a huge amount of pressure right now.
There's an article in Barrens this morning by Tay Kim.
The headline is not what NVIDIA's comms teams would have liked it to be.
The headline is, Nvidia says it's not Enron in private memo refuting accounting questions.
That's a crazy thing to say.
Of course, it's not Enron.
Let me get it to the coverage.
So Tay says a series of prominent stock sales and allegations of accounting irregularities have put
in the middle of a debate about the value of artificial intelligence and its related stocks.
Now, NVIDIA is pushing back in a private seven-page memo sent by NVIDIA's investor relations team to Wall Street analysts over the weekend.
The chipmaker directly addressed a dozen claims made by skeptical investors.
NVIDIA's memo, which includes fonts in the company's trademark green color, begins by addressing
a social media post for Michael Burry last week, which criticized the company for stock-based
comp, dilution in stock buybacks. Barry's bet against subprime mortgages before the 2008 financial
crisis was depicted in the movie The Big Short, of course. NVIDIA repurchase 91 billion shares
since 2018, not $112 billion. Mr. Burry appears to have incorrectly included RSU's. RSU taxes,
employee equity grants should not be conflated with the performance of the repurchase program.
NVIDIA said in the memo, employees benefiting from a rising share price does not indicate the original equity grants were excessive at the time of issuance. That makes sense. Barron's reviewed the memo, which initially appeared in social media posts for the weekend and confirmed its authenticity. Burry told Barron's he disagrees with NVIDIA's response and stands by his analysis. He said he would discuss the topic of the company's stock-based comp and more details. Burry is, of course, now over on substack. He's charging $380 a year.
And if you are a perma bearer, I can't.
This is like Christmas coming early.
Nvidia didn't respond to Barron's for a request for comment,
but they also responded to claims that the current situation is analogous to historical accounting frauds, Enron, WorldCom, and Lucent,
that featured vendor financing and SPVs.
Nvidia does not resemble historical accounting frauds because Nvidia's underlying business is economically sound.
our reporting is complete and transparent, and we care about our reputation for integrity.
Unlike Enron, NVIDIA does not use special purpose entities to hide debt or inflate revenue.
There's no market.
There's 25 examples of how this is not the same.
Nvidia also addressed allegation that its customers, large technology companies aren't properly
accounting for the economic value of Nvidia hardware.
Some of the companies use, we've talked about this,
uses a six-year depreciation schedule for GPUs.
Burry said he believes the useful lives of the...
the chips are shorter than six years, meaning Nvidia's customers are inflating profits by spreading
out deep depreciation costs over a long period.
Nvidia's customers depreciate GPUs over four to six years based on real-world longevity
and utilization patterns.
Older GPUs such as A-100s continue to run at high utilization and generate strong
contribution margins, retaining meaningful economic value well beyond the two to three years
claimed by some commentators.
So again, under fire on the TPU front and from the Michael Burry camp.
But again, I think their answers are totally valid.
Matt over on X said, had a post here.
He said the TPUs equal bad for NVIDIA take is up there with the dumbest,
maybe worse than Deepseek, as it completely misses what actually happened in the last six weeks.
and I will remember who is who in the zoo, my view.
One, demand for AI is bananas.
No one can meet demand.
Everyone is spending more.
Google said just yesterday they have to double capacity every six months to keep up.
Two, scaling laws are intact.
He's referencing Gemini 3.
The flywheel is about to speed up.
Somehow the mid-curve crew thinks this is zero-sum competition.
None of this suggests that.
If you think the race is hot now, wait until you see what comes out of large, coherent blackwell clusters.
All the magic from the quote God Machines is pretty much still hopper-based.
Lastly, a quick GPU, less than the cost and performance specs on the box aren't what you get in real life.
And Google is going to get a bat margin two.
Double-da.
What matters is system-level effective tokens to watt to dollars in TCO.
Invita GPUs have higher FMU because they're already embedded in workflows slash the ecosystem is massive.
By the way, this is a good test.
If you have an opinion on this topic,
but you have to look up FMU, then perhaps curate better source.
MFU.
What?
MFU.
MFU.
What I said?
FMU.
Sorry.
The above effective token watt gap also likely widens with Rubin.
Add in that Jensen can actually deliver volume in a tight market,
plus future flexibility, multi-cloud capable,
programmable for paradigm shifts,
and he'll sell every GPU he makes for years.
Google will too, since everyone wants a second supplier
and TPU is a fantastic chip,
but this is as far from either or as it gets.
The one benefit of this confusion
is that it is likely to give Google a brief stint
as the world heavyweight champion,
the most valuable company.
I would guess the midwits put the strap on them
in less than two weeks.
So he is...
Put the strap on them?
What does that mean?
Just like...
Like pile in?
Is he saying just like...
So he...
It seems like he's...
predicting that that people will overplay the Nvidia bear take and overplay the Google
opportunity and that will result in Google becoming the most valuable company in the world
and he uses the phrase put the strap on them in multiple in less than two weeks
interesting post in other news David Sachs has hit the timeline he says according to
today's Wall Street Journal AI
related investment accounts for half of GDP growth, a reversal would risk recession.
We can't afford to go backwards.
We will, the article is how the U.S. economy became hooked on AI spending.
And we will be chatting with Kratios in about an hour on this very topic.
So we can get into a little bit.
Before we move on, let me tell you about Adio, AI Native CRM,
Addio build scales and grows your company to the next level.
Fact sheet from the White House, President Donald J. Trump unveils the Genesis
mission to accelerate AI for scientific discovery.
Today, and this is yesterday, today Trump signed an executive order launching the Genesis
mission a new national effort to use artificial intelligence to transform how scientific
research is conducted and accelerate the speed of scientific discovery.
The Genesis mission charges the Secretary of the Secretary of.
energy with leveraging our national laboratories to unite America's brightest minds, most powerful
computers and vast scientific data into one cooperative system for research. The order directs the
Department of Energy to create a closed-loop AI experimentation platform that integrates our nation's
world-class supercomputers and unique data sets to generate scientific foundation models and power robotic
laboratories. The order instructs the assistant to the president for science and technology
to coordinate the national initiative and integrate an integration of data and infrastructure
from across the federal government.
The Secretary of Energy APST and the Special Advisor for AI and Crypta will collaborate
with academia and private sector innovators to support and enhance the Genesis mission.
Priority areas of focus include the greatest scientific challenges of our time that can
dramatically improve our nation's national, economic, and health security, including
biotechnology, critical minerals, nuclear fission, and fusion energy, space,
exploration, quantum information science, and semiconductors, and microelectronics.
Next, harnessing AI for our national security and economic development with the Genesis mission.
The Trump administration intends to dramatically expand the productivity and impact of federal research and development within a decade.
So there's one more note here on strengthening America's AI dominance.
Trump continues to prioritize America's global dominance and AI.
to usher in a new golden age of human flourishing, economic competitiveness and national security.
And so we will get into more of this with Kratzios.
Yeah, I'm very interested to hear how the public-private partnership actually works here.
There was a time when basically every cool technology was coming out of DARPA,
coming out of the U.S. government. The U.S. government landed on the moon.
and since then, you know, I think a lot of people in technology have lost faith in the U.S.
government overseeing the development of technology.
Even academia.
I mean, people think, like, you know, AGI will emerge from a private C-Corp.
Like, that's where people believe that the best work will be done with, you know, give Ilya
Sutskiver, give the best scientist $3 billion, let them go cook.
Like, that's the thesis currently in tech.
this feels like somewhat of a rejection of that in some ways.
There's obviously lots of different places where having AI resources, having science and technology resources within the government make a ton of sense.
But it'll be interesting to see like where are the interfacing points between the two categories, the public and private sector.
Because by default, I think most people in our audience in technology would,
would say, hey, let's leave the space travel and the AI research to the private sector.
And this is, you know, potentially a different direction, potentially just very synergistic.
So it'd be interesting to see where it breaks.
Well, should we run through the Astral Codex 10 piece on trait-based embryo selection to tee up our discussion with Kermu and Kian from Nucleus and go through that?
So this is from Scott Alexander in AstroCodex 10.
He said suddenly trait-based embryo selection.
When a couple uses, I, so in 2021, genomic prediction announced the first polygenically
selected baby.
When a couple uses IVF, they may get as many as 10 embryos.
If they want one child, which one did they implant?
In the early days, doctors would just eyeball them and choose whichever looked to the
healthiest.
Later, they started testing for some of the most severe and easiest.
to detect genetic orders like disorders like Down syndrome and cystic fibrosis.
The final step was polygenic selection, genotyping each embryo and implanting the one with
the best genes overall.
Best in what sense?
Genomic prediction claimed the ability to forecast health outcomes from diabetes to schizophrenia.
For example, although the average person has a 30% chance of getting type 2 diabetes, if you
genetically test five embryos and select the one with the lowest predicted risk, they'll only have a 20%
chance. So you get a 10% bump there. That's nice. Since you're taking the healthiest of many embryos,
you should expect a child conceived via this method to be significantly healthier than one born
naturally. Polygenic selection straddles the line between disease prevention and human enhancement.
In 2023, Orchid Health, founded by Noor, who we've had on the show, enter the field. Unlike
genomic prediction, which tested only the most important genetic variants, Orchid offers whole genome
sequencing, which can detect the de novo mutations involved in autism, developmental disorders,
and certain other genetic diseases. Critics accuse GP and Orchid of offering designer babies,
but this is only true. In the weakest sense, customers couldn't design a baby for anything
other than slightly lower risk of genetic disease. You're basically just selecting out of what
you already got. They're not editing the genes. They're merely sequencing them and then allowing
you to select. These companies refused to offer selection.
traits, the industry term for the really controversial stuff, like height, IQ, or eye color.
Still, these were trivial extensions of their technology, and everyone knew.
It was just a matter of time before someone took the plunge.
Last month, a startup called Nucleus took the plunge.
They had previously offered 23-Me-style genetic tests for adults.
Now they announced a partnership with genomic prediction, focusing on embryos, although GP
would continue to only test for health outcomes.
You could forward the raw data from GP to Nucleus and Nucleus.
would predict extra traits,
including height, BMI, eye color,
hair color, ADHD, IQ, and even-handedness.
And it's worth noting that nucleus
is now being sued by genomic prediction.
Even though they have this partnership.
I'm assuming the partnership is no longer.
Well, we can ask.
But I'm assuming it's no longer
because one of GPs co-founders
left the company to join nucleus.
Interesting.
and allegedly turned off all the security cameras.
Is that metaphor?
Or is that actually?
No, the lawsuit alleges that he turned off all the security cameras on his last.
That's not a metaphor for like, you know, sharing a Google Drive of PDFs.
You literally mean...
It's his last day at work.
And he was allegedly like rounding up.
Okay, so he turns off the cameras allegedly.
And the implication is that maybe he was rummaging.
around like literally taking documents or something like that. That's at least what the timeline is
what the lawsuit alleged. Okay, wow. That's wild. I did not know that that was a literal
accusation. And then another part of it, apparently Nucleus, it's new people at Nucleus were
emailing the former co-founder at his old email address, evidence of that.
them violating the agreement that they had.
So anyways, it's very, very, very, very messy.
We can ask.
Yeah, there's like four or five companies involved in this.
And all of them are controversial because this is the most, I think the most controversial,
probably like category that you can be in.
Yeah.
It's certainly up there.
Health is already like one of the most controversial topics.
Yeah.
Everyone has an opinion on it.
Health influencer that you've gotten into.
Totally.
various debacle.
Yeah.
And also there's just like the, there's just, it's so easy to throw, I mean, in the same way that
people are throwing Enron at, at Nvidia, like, it's so easy to throw Theranos at any
biotech company that's not, you know, that's accused of anything.
And, and also biotech, it's like, it's pretty hard to understand the underlying science.
It's not, it's not, it's not as popular as, okay, like, does the website work?
Does the business make money?
You know, what's the cash flow like?
It's way more complicated.
And so it does attract even more attention.
So one of the other companies in the space is Heresite.
And Astral Codex 10 continues here.
They enter the space with the most impressive disease risk scores.
Yet an IQ predictor worth six to nine extra points and a series of challenges to
competitors whom they call out for insufficient scientific rigor.
Their most scathing attack is on nucleus itself, accusing its predictions of being
misleading and unreliable. Let's start with the science and then move on to the companies to see
if we can litigate their dispute. In all theory, in theory, all of this should work. Polygenic embryos,
polygenic embryo screening is a natural extension of two well-valided technologies, genetic testing of
embryos and polygenic prediction of traits in adults. So genetic screening of embryos has been done for
decades, usually to detect chromosomal abnormalities like Down syndrome or simple gene editing disorders like
cystic fibrosis. It's challenging. We've talked about this before. You need to take a very small
number of cells, often only five to ten, from a tiny protoplasenta that may not have many cells
to spare and extract a readable amount of genetic material from this limited sample. But there are
known solutions that mostly work. And so the companies that we're talking about today aren't
necessarily doing like the fundamental lab equipment development, building the machine,
figuring out how to sequence data from the first. It's more about the analysis that happens on
top of the results. And the recommendations. Which is probably, which I would say is the most
controversial part of this. I don't know that any of them are recommending, hey, we think you should take,
we think you should pick this baby. They're more just saying like, we think that according to the data,
this baby might be taller than this one. But if you're giving somebody risk fact, if you're,
yeah, but that's not a recommendation. Like, if I tell you, this car is 700 horsepower and does
0 to 60 in 2 seconds, and this one does 800 horsepower and does 0 to 60 in 2.4 seconds,
this one's faster in a straight line, this one's faster on the curves, and then like you pick,
like, I didn't make a recommendation. I just told you the stats, right? Yeah, but from when you
look at these companies from what they're marketing to consumers of what, of why you should
care about the service.
Sure.
And then the way that they deliver the information, if they're advertising, we can effectively
advertising, we can help you have a smarter, healthier baby.
And then they're saying like, hey, we think this direction is going to get you a higher IQ.
I don't think it's a recommendation.
It's not an explicit recommendation, but I think people are trusting the service to try
to get them what was marketed to them.
Yeah.
People want the data.
and they want the data to be accurate
because they're going to make a decision based on that.
But I mean, here, Scott Alexander
actually gets into some of the complexity
of the actual trade-offs
because there are...
So most traits are polygenic,
requiring information about thousands
or tens of thousands of genes to predict.
These are too complicated to understand fully
at current levels of technology,
but some studies have chipped away at the problem
and gotten to a partial understanding.
Often, this looks like being able
to predict a few percent of the variance in the trait to determine whether someone's genetic risk
is slightly higher or lower than average.
And so some people might genuinely want to select on a single condition.
For example, people with a strong family history of schizophrenia might want to minimize
their chance of their children getting the disease.
For these people, reducing schizophrenia risk by 58% while keeping everything else constant
sounds pretty good.
Everyone else probably wants a genetically healthy, generically healthy embryo with low risk of all conditions.
Exactly how this works depends on the customer's own value.
Would they prefer an embryo with lower cancer risk to one that will have fewer heart attacks?
Like, that's a trade-off that you have to pick.
And the exact benefits will depend on how parents make that decision.
Genomic prediction and heresite try to help by providing semi-objective measures of which embryo is overall healthiest
according to different conditions, effects on longevity and patient-rated quality of life for genomic
prediction. That's the embryo health score. This is, you know, that's close to a recommendation.
I think you're, you're getting close. Yeah, and Nucleus's subway campaign is have a healthier baby.
Yeah. Yeah. It's, it's, it's, the, the, the, the marketing claims are, are a big, big piece of this.
I think, I think, I think the scientific claims are potentially, uh,
just as important, but they're both understanding where the science actually is, both broadly,
and then also within the companies, and then how it's marketed. All of that is important
to get like a complete picture of what's going on here. So for Herasite, it's a polygenic
longevity index. They don't give exact risk reduction numbers for each disease, saying that it depends
too much on a couple specific family history, but say that most people gain one to four years of
healthy life. When I test it on a set of 20 embryos, the healthiest gets an extra 1.66 years.
And so how much would you pay to give your children an extra one to four years of healthy life?
This is no longer a hypothetical question. Here are the costs. Genoic prediction is around $3,250.
Orchid is around $12,500. Nucleus is around $9,249. And Herosite,
$53,250.
That is expensive compared to the rest, five times the price.
Is it worth it?
Well, if you're already doing IVF, the claimed risk reductions are accurate,
you value your kids' health as much as your own, you have low time discount rate,
you're well off enough that these aren't extraordinary sums of money to you,
you're okay using expected utility calculations where a 50% chance of preventing X is half as good as fully preventing X,
then I'll go out on a limb and say, yeah, it's obviously it's worth it.
consider genomic prediction, which costs $3,500 for five embryos and claims to lower absolute risk
of type 2 diabetes by 12%. That implies that not getting type 2 diabetes is worth $27,000.
Ask anyone dealing with regular insulin injections, let alone limb amputations, whether it would
be worth $27,000 to wave a magic wand and not have type 2 diabetes. It's not a hard question.
And that's just one of a dozen conditions you can lower the risk for. Other ones, like not getting
breast cancer might be so valuable that it's hard to even attach numbers. So what about IQ?
Six extra IQ points, which is Harrisite's estimate with five embryos, is about a quarter of the
gap between the average person and the average Ivy League student. The benefits of intelligence
are hard to quantify, but it's been shown to have probably causal positive effects on income,
mortality, and achievement. Probably the income effects alone make up for the cost of the intervention.
again, assuming total parent-child altruism and a low discount rate.
So if we accept all of these claims and assumptions, the choice seems obvious.
It probably even accounts, it's probably even obvious for governments to pay for all citizens to get these,
given how much they'd save on health care costs, says Scott Alexander.
But in practice, it's complicated.
Critics have raised both scientific and ethical objections to polygenic embryo screening.
Most significantly, it's been condemned by various bodies, including the society for
psychiatric genetics, the European Society of Human Genetics, and the behavioral genetic society.
Their statements are not good. They tend towards vague language about how people are more than just
their genes, or how no genetic tests can be perfect, or how embryo screening is not exactly
the same thing as some other form of screening, which has a longer history and more proponents.
Although, quote, although in general higher scores mean you are more likely to have a condition,
many healthy people will have higher scores.
Others might develop the condition even with a low score,
says the Society for Psychiatric Genetics,
as if they have just blown the lid off of some dastardly conspiracy.
Screening embryos for psychiatric conditions may increase stigma surrounding those diseases.
They continue.
An objection which, taken seriously, could be used to ban every form of medical treatment.
Because if you take care of something, you remove them from the population,
that might increase the stigma, but we should still treat these.
So he says, we will mostly ignore these people.
and try to imagine the implications of the objections that mildly competent credits might raise,
some of which will coincidentally overlap with the content of the non-hypothetical statements.
So the big question he wants to answer is scientific objection,
the scientific objection around efficacy.
Does this, are we sure where this works at all?
Are we sure this works?
So a typical polygenic score is created by collecting thousands or millions of adult genomes,
then matching genetic information with surveys about who has the trait slash condition of interest.
Reputable studies then test these scores on holdout samples, adults who are not used to make the score,
to see if they still accurately predict who has the trait slash condition.
Polygenic embryo selection depends on an assumption that the scores which work in these kinds of
retrospective tests will also work on prospectively on embryos.
This assumption hasn't been formally proven in studies, which would require years or decades to conduct, but seems common-sensical.
The strongest challenge to the application of polygenic scores for embryo selection comes from a recent body of research showing that most scores combine causal genetic effects with population stratification and therefore can be expected to lose much of their predictive power when comparing two members of the same family.
there is an increasing agreement in the field
that unless scores are validated within families,
headline results like decreases risk of X by Y percent
will be large overestimates.
When I talked to company representatives,
they all said that they took accuracy extremely seriously
and had various white papers and journal articles
where anyone could double-click,
could double check on their methodology.
But I attended an industry conference a few months ago
and the gossip level was comparable
to a high school cafeteria.
It says minus the sex rumors most of the attendees were having their kids via IVF.
Everyone had some story about someone being careless or fudging their numbers.
Some of the conflicts broke out into the open on Wednesday when Heresite left stealth and published a white paper and associated blog post.
They criticized genomic prediction for reporting between family rather than within family results.
and Orchid for smuggling a term for age into their Alzheimer's predictor.
Unsurprisingly, this makes it work better.
We'll get to their accusations against Nucleus below.
Note that this was recent enough that competitors haven't had time to air their own criticisms of parasite if this happens.
I'll try and keep you updated.
And to be clear, this article is from around five months ago.
Yes.
And since that time,
nucleus has been accused of plagiarizing the paper from heresite from harrisite right from harrisite
yeah um and then also accused of stealing IP from genomic prediction so there's again a bunch of
different accusations we'll let yeah so yeah yeah i mean the the goal here is uh is to just give
an opportunity for you know cremew and keon to uh to answer some questions try and contextualize it
and make their case to a broader audience.
They're, you know, I've read through as much as I could, I can,
but without actually getting in the lab and rolling up my sleeves,
I don't think I could come to a firm conclusion here,
but I can certainly talk to them on this show and hopefully get some more information
that the community can do with what they will.
So Scott Alexander concludes this section talking about his strongest
opinion of the scientific criticism. He says, authorities on all sides have cited Alex
Young as an authority on how polygenic scores can be confounding or misleading. Last week, Alex
Young revealed that he had been working with Harrisite while it was in stealth mode and endorses
their research. Three, L.O.L. Probably that means Harrisite's products are okay. That serves as
proof of concept that this technology can work and means other companies' claims are at least
plausible. So lots of back and forth, and we will be joined by by Cremu in just a few minutes.
I actually need to message him and make sure that he has the information. Is there anything else
that you think would be worthwhile to discuss before we hop on? Let's...
Yeah, and I can just go through. I mean, the original accusations came from an account called
Sichuan Mala.
Sushan Mala, yes.
Who wrote an extremely lengthy blog post on a bunch of the issues that they felt they had found with Nucleus.
Nucleus ended up firing back and saying that Sichuan Mala was, or sort of implying that Situan Mala was funded by a competitor or competitive service as well as making those allegations with Kramu.
They go into issues around potentially fictitious customer reviews, which we'll ask you on about AI-generated blog posts, accusations of intellectual property theft, saying that the nucleus origin, white paper is plagiarized, saying it that has a bunch of errors.
Nucleus has responded already to a lot of this stuff.
Well, our first guest to the show is here.
Let me tell you about linear.
Meet the system for modern software development.
Purpose built tool for planning and building products.
We will bring in Kermew from the Restream waiting room into the TVP and Ultradome and have him set the table for us.
Kermew, how are you doing?
Welcome to the stream.
How are we doing?
Glad to be here, guys.
Thanks so much.
Good as always.
Looking good.
By the way, I can go face docs if you want.
Let's do it.
Let's do it.
We can show his actual video this time, which is great.
We've had him, welcome to the show.
Hey, hey.
Good to see you.
How you doing?
What actually kicked this off for you?
Do you know, Sichuan Mala, separately, independently?
Did you know that this was coming?
Set the table for us, like, why did Nucleus come to the top of your mind?
So, can I actually go back to Hereticon?
Please.
With this?
Yeah.
All right.
So for about a year, we've told Nucleus about issues with their products.
Can I just actually give a big, like, I can model log on this for a minute.
I can tell you a lot of the details that you want to go into it.
Go right now.
Okay.
So one of the early things that really peeved a lot of us who are aware of how this tech works
is that Nucleus claimed to provide parents with information about rare variants based on microarray files.
Their website's wording is incredibly ambiguous.
So the excuse when I raised this to Key in person was that they were referring to imputing a child's
embryo or a child or an embryo's microarray-based data with parental whole genome data.
But this is not sufficient for rare variants like they claim it is, and it only works out
in very well and narrow, well-behaved cases.
It's not a clean substitute for sequencing an embryo or child.
The rare variant information they can offer is limited and their claim is highly misleading
because it sounds like they can achieve coverage of de novo rare variants and ultra-rare variants
reliably for children and embryos, but they cannot do this because of like crossover that happens
during recombination inside the haplotype blocks you're using through the imputations
and because of mutations. They can't even get high confidence coverage of rare variants more
generally, which is what their big claim is about in specific wording with the imputation-based
methods they claim to be using. So everything they say has a huge error bar on it and they shouldn't
be advertising it basically. It's something incredibly misleading. So just to like actually
zoom out, like, what do you think they are capable of doing?
I think they are capable of microarray sequencing.
I think they're capable of...
I mean, I mean, I mean, in terms that you could advertise to a parent.
Like, you could, like, if Keon went to a prospective parent, the parent says, I'm doing IVF, what can you do for me?
Is this category even ready for large scale, out of home advertising?
Do you think, do you think, it absolutely is?
The issue is that nucleus should not be doing it because nucleus has produced scores that are invalid.
They're incredibly invalid.
Like, for example, they used an ADHD score that included 12 single nucleotide polymorphisms.
They claimed it explained 4% of the variance in ADHD, which means it's a pretty good predictor and you can use it to get some improvements in the margins.
But 12 SNPs means that there's just no way.
They could explain less than 1% of the variance.
and the best current ADHD polygenic score uses more than a million snips and explains about 1% of the variance.
So they just basically lied.
They made up these numbers.
And Harrison had to go through and show that, oh, actually a bunch of their numbers are made up.
Yeah.
I mean, how do you know for sure that they're, I mean, like that claim, you know, the state of the art was, was a million for one percent.
Now it's 12.
Nuclase is claiming 12 for 4%.
That seems like a huge exponential growth in efficacy of that particular test.
But just an exponential progress is not necessarily evidence of malfeasance, right?
This isn't progress.
They've never been able to show that they can use 12 snips, and no one can.
It's impossible.
They don't explain this much variance.
It's literally physically impossible.
It's not possible in any way.
They should never have claimed it.
They should never provide its score reports to people based on it.
it and they did. They provided customers with score reports that have to be fake. Not fake per se,
but they have to be incorrect. They have to be wrong. There's no way they could stand up to scrutiny.
What I'm saying is that after they made this 12 snips to 4% variance claim, people have looked
and they've shown the latest ADHD polygenic score, which is more recent than what they've claimed
to have on offer, uses more than a million snips and explains about 1% of the variance.
It's just that's the state of the art. They are claiming to have better than the state of the art
with completely implausible parameters.
It is impossible.
Okay, so back to the original question,
like what do you think they actually could offer,
even if they say, hey, you know what,
we're not necessarily state of the art.
We're partnering with a lot of different labs.
We're standing on the shoulders of giants.
We're using the tools that are available.
What is a reasonable claim that if they made it,
you would be like, yeah, that sounds reasonable.
A reasonable claim from Nucleus is that they are pulling polygenic scores from the polygenic
catalog, a publicly available resource that lists a bunch of different polygenic scores
from different genome-wide association studies.
That would be reasonable.
But that is not a, why would you go with them then?
They have nothing unique to offer.
What they have offered that seems to be unique are claims that don't hold up to scrutiny
or which are clearly plagiarized from one of their competitors.
Yeah.
Well, there are plenty of services that are like, you know, in, you know,
you know, effectively wrappers around Quest Labs.
And, you know, I get a better UI, and it tells me that my cholesterol is in the range.
And yeah, I know it's just looking up the range from the data, but it has a nice UI and a reasonable billing system or whatever.
And people pay for that.
And they get, you know, they make decisions about their diet based on that.
And I don't think that there's anything necessarily wrong about providing something that's a commodity or not a scientific breakthrough.
As long as you're up to, as long as you're honest about what you're doing.
you're not inflating the results.
Yeah.
The problem is that they're inflating the results.
Okay.
The problem is that they are effectively making up the results.
They have actually,
in their latest report,
they have claimed to basically match heresite,
not claimed it directly.
They've copied their very unique citations,
which no one else has made.
They've copied their method.
And copying their method is incredibly weird.
You mentioned there that Scott Alexander noted that Alex Young is,
um,
yeah,
like seen as a big authority.
in this space. And it's true. Alex is seen as like the go-to guy. If you want to learn about
family-based sampling, trio imputation, if you want to learn about within family validations or
imputations or quality control, you ask Alex. That is the thing to do. And they apparently
copied Alex Young's quality control pipeline. And it's very unique. So doing this is unusual.
It's unheard of. It's not likely to have actually been done. It is like saying that you woke up one day
and here's my morning routine. I woke up and today I was John Kugan and I brushed my teeth
exactly three times each time around and I went and prayed to my household God and I did all sorts
of things and it's just it's incredibly specific in a way that is very unlikely to be real.
They've very likely just kind of mimicked exactly what they said and they said they did it on
additional data but their results came up very close.
Yeah, yeah.
Which is not likely. We have strong theoretical genetic reasons to expect that if they
have this additional data that Heresite did not, the results would have actually looked different.
So they have all these signals that they didn't do the analyses they said they did and lots of
indications that they plagiarized. And when Sichuan Mala called them out, they responded. The response
they generated was amateurish. It was kind of embarrassing because they admitted simultaneously to
denying they did the plagiarism. They admitted to doing the plagiarism. They copied, they admitted they
copied things directly from Heresite. They admitted they use resources that are unusual to use,
and they effectively got the data from them. And they did nothing that was really unique,
but they did aid. So copying might be, you know, looked down upon. In tech, people copy stuff
all the time. The stories was copied into Instagram from Snapchat. Different machine learning
architectures are being copied constantly. Some stuff can be patented. Some stuff can be,
trade secrets. Are we looking at anything that's that goes beyond just like, yeah, it's kind of bad
form to copy? Or is this something that's actually like a problem beyond that? Yeah, would you,
would you be less angry if they copied it perfectly instead of like sort of copied it directionally?
They copied a lot of it perfectly. And this leads to weird results because they should not
have done that given the cohorts they used. They used separate data for their validations.
the results should have been different. They copied details that made it apparent that they were not
using the data they claimed to or they were just fudging the results. It has to be one or the other.
There's no way that could have gotten the results they did with the data they did and the
copying they did. The copying tells us that they lied about something somewhere along the way.
There is something fishy here. And we don't know what the exact error is. We just know they
have to have made an error because there's no way that the additional data they had access to
was identical to all the data
their competitors used.
It would have delivered different results.
So I wanted to ask,
they released open weight models,
the origin models.
Part of their,
part of their pushback
against Sichuan Mala's critique
is that anybody can just
download the models
and play around with them.
Have you downloaded them?
So you have to ask for access
and they do not give out access.
We've had multiple people
go in and try and ask for access and they've not received it at all. And one person who asked
for more information was told, stop contacting us. So no, they are not open at all. They're
open in the sense that opening eye is open. They're not very open. Okay. Got it. Shifting gears to the
marketing claims. What stuck out to you there is particularly in need of addressing?
They very much need to address the fact that they
seem to have fake reviews. So when they started nucleus embryo, they launched it in June.
They weren't offering any sort of embryo screening services beforehand. And if they were,
then it would have been how. They would have, they have to specify what lab they use for all
this. There's a lot of details that should go into this that they can't actually specify because
they didn't do that. So they claim to have had customers that have already been served by this.
Well, as everybody knows, it takes about nine months to serve a customer in this at minimum.
Yes. And it is not when nine months.
A big in one month.
It takes that months and whatever.
So I'd love to see these three-month-old babies that came out perfectly and made their customers so happy.
But I don't think they exist.
I think they're not real.
So why do they have these reviews?
I don't know.
And the reviews are also, they have a lot of fake elements.
There are some that are clearly fake.
So they use stock images in these reviews to show their customers.
Which to be clear, you can imagine a scenario where they use stock imagery and fake.
names and they put an asterisk and say due to HIPAA compliance reasons we're not just publicly
displaying you know the names of any of our clients but there's there's no issue revealing this
stuff and other companies do actually reveal the real customers so orchid has revealed real
customers I've been introduced I've met Harrison customers oh yeah didn't Jason Carmen do a whole
video with nor and the first in the first orchid baby and this has been like basically
making a documentary about that person's journey like there's no
like, and I feel like I see in drug commercials all the time.
It'll be like, this is a real customer who loves this hair loss meds.
And they're like, yeah, it looks great.
Yeah, but there's regulations around out.
It seems much harder to get, it's probably much harder to get somebody to opt into that
than just opt in to generally providing.
Sure.
Clearly, clearly, yeah, yeah, yeah.
Is that, is that legit, you think?
No, they still could not have had the babies in time.
It doesn't fit with the time.
The chronology doesn't work here.
These customer reviews are not really physically possible.
And I'd like to see an explanation from them because it doesn't make any real sense to me.
They could be, I don't know, making some sort of representative review that they've maybe hedged in some fine print on some page somewhere.
But I haven't seen it.
And their entire site has been archive now.
So if that page exists, they'll have to show it to us on the archive.
One thing Jordy and I were debating was this big question of like, is nucleus making a recommendation or not?
I don't know if this is relevant, but I would love your take on this.
this idea of like, you know, I see a, see an ad that just says, like, height is an 80%
DNA based or genetically inheritable. And then you go into the dashboard and it just says,
here's the predicted height and here's the predicted, you know, IQ. And then you make the
decision. And it's not necessarily, they're recommending one or the other. It's more of a diagnostic
and you can do that information what you want. Does that, does that absolve them of some sort of
responsibility there? No, it doesn't. So if you,
you still provide wildly and accurate scores, then it doesn't matter what you're recommending.
You are effectively just recommending something that doesn't matter. I mean, you are giving them
incorrect recommendations. You have to give some range of uncertainty within the best of your ability.
You have to give them something that is to the greatest extent knowable, reliable. And they
can't have done that. They've provided scores that they know, they must know are incorrect.
You can't explain 4% of the variance with 12 snips. It's not really feasible. There's no possibility
of it, really. There's also
no possibility of getting high
confidence coverage on rare variants to make
from the imputation methods they've
described, so they can't make parents certain
about this stuff. They're saying lots of things that are
that would require them to
basically advance the science 20 years.
They would have to be leaders
in innovations here. And
I just kind of doubt it. The
people who are actually leading on the innovations here are
Heresite. Orchid is doing
so as well. They're doing a lot of orchid's whole
genome sequencing of embryos is
the only one of the industry available to do this. And Heresite's innovation is that they made this
stuff low cost for what they have admitted is a reduction in quality if you get PGTA-based
imputation. Now, another thing I do want to mention, though, is that nucleus might, and we're still
looking, I'm still looking into this. I'm collecting some patient reports. I found one from my friend
Dylan. She got a report from Nucleus, and she got one from Invitating. It was a whole genome sequencing
thing done. And Nucleus, and I did see the report, Nucleus said she had a
a medeilian disorder, a monogenic disorder caused by one gene, and Infante said she didn't have it.
Okay, this is weird. So what's the inconsistency we don't really know?
Nucleus recently changed this result. Now, per the law, you have to notify your customers if you change their sequencing results.
This is a CLIA regulation, the CMS regulates this, and that is a potentially major issue that they might be out of compliance with.
And I understand that startups are often out of compliance, and a lot of them,
and fake it till they make it in terms of following the letter of the law. But I'm of the opinion
that they really shouldn't, especially because this is serious tech with major implications for people,
their families, and I mean, all future generations of their families. This is, as I think Jordy called
it, bloodline optimization. And we have these rules in place for a reason. You need to show you're
abiding by them. Yeah, how much do the other players in the category, how much are they worried
about nucleus just kind of setting back the entire category.
So I have gotten, it's on video, and because Keen tweeted about being in it, and I'm allowed
to say that we were at a private conference, and I did lead a panel on this topic where
Keen was one of the panelists and the heads of some other embryo selection companies were also
on the panel as well. And I will say that everyone was worried. Everyone was worried about one of the
major missteps that actually has already been addressed by another one of the companies,
and the series of major missteps made by nucleus that they have failed to address.
I warned Keene about this stuff many months ago.
I've warned him about problems for more than a year now, and he has simply not addressed
them.
They're still there on the website.
You can go find them.
I've archived these pages a few times to see, are they getting to them?
Are they getting to them?
The answer is no.
They are still making claims that are either not possible, not possible with the current tech,
might be possible in 20 years or just don't seem consistent with the evidence that they provided
to their customers.
Okay.
Last question.
And then we're going to hop on with Keon.
I'm a big believer in redemption arcs.
You're obviously unhappy with Nucleus's behavior in the industry.
What does redemption look like?
What would Keon have to do or show you to get back in the good graces of the industry in your good graces?
So the whole industry knows that Kean has been a problem for a while. And we actually, a lot of people have tried to give him a redemption arc already. They have tried to come to him. They have given him clear advice on what he needs to do. They have told him, you need to stop making X, Y, Z different claims. They have told him you need to offer scores that are vetted. You need to be open about your vetting. You need to be open about your sources. You need to qualify everything like the other companies do. But you haven't. He has been told this for a,
long time. I sent you some pictures earlier today. You can see the panel we're on where clearly
like this has been a thing that's come up a lot and we wanted to give them the arc already, but it came
to this. It came to a person going online, a blogger deciding, hey, I'm going to look into this
after reading the various blog post and saying, well, shoot. So to make up for it, I think they
would need to be incredibly open and they need to apologize and they need to admit to what they did
wrong and they need to say that they were out of compliance with Cleo rules and regulations and
they need to say, hey, we might have misstepped here or there.
We didn't know we were doing this or whatever.
Like, whatever it takes to be accurate.
Document everything.
Tell us everything you've done.
Tell us all the missteps.
Don't exaggerate.
Do not lie.
Just be upfront with everyone and submit yourself to regulation.
Not in the sense that you have to go and tell the regulator you want to like implement
whatever new rules and regs, but submit yourself to openness.
Be really open.
Stop this whole thing about not telling us your methods, which they've done.
Citron Mala has documented that in the latest blog post.
And give us your data.
Give your data out.
Stop provide, like saying it's going to be available upon request.
It doesn't matter if your competitors have it.
Offer better pricing or something.
Compete on some other margin because we shouldn't have to compete on trusting you.
I'm saying we, I'm not talking.
I don't have a company in the space, but everyone should be trusted.
All the companies in the space need to shape up a little bit and they need to be a little more open.
And Keen needs to do that the most.
Thank you for coming on the show and breaking it down for us.
appreciate you taking the time and walking through all of that. Have a great rest of your day.
Who knows, you might be on the show very soon as this debate continues. So we really appreciate
you taking the time. Thank you. Talk soon. Have a good old guys. Bye.
Before we bring in Keon, let me tell you about fall, build and deploy AI video and image models
trusted by millions to power generative media at scale. And we have Keon from Nucleus in the
Restream waiting room. Let's bring him in to the TBP and Ultron. Kian. Kian.
Good to see you. I wish it was less dramatic circumstances, but, you know, it makes for good TV. And we're happy that you're here and we can chat about this. And I mean, I'd love to just give you the floor. I'm sure you saw, you know, some of the early segments. Where do you think it's important to start? Where do you think it's most important to set the record straight as the first point? And then I'm sure we'll have a bunch of questions.
Well, I didn't see what Kramu said.
I was busy helping a patient.
But I think the key thing to remember is that Kramu and I, we are definitely aligned on doing great science.
At the end of the day, that we want to do.
We want to serve the patient.
We want to do amazing science.
I think what we're not aligned on is Kramu basically for several months has not disclosed that he's been affiliated with a competitor.
And, you know, that wouldn't be so much of a problem unless they're basically concerning together.
And so that's on the Khrmoo side of things.
Well, honestly, that's like the less important thing to me.
Yes, I agree.
I think that's less important.
So I've seen him post positively about your competitors.
I've not seen any proof that he's actually being paid or has equity in that competitor.
But to me, it almost doesn't matter.
It could like every single post from him and Sichuan Mala could literally be from Norrit, Orchid, or someone at one of your competitors.
You still need to address it, right?
100%
and so first and foremost,
I'm going to say that our science
is completely public
and it's been completely public.
So one thing that it's really important
to say is that anyone.
And by the way,
we back at this point
have shared our models
with over 15 different entities,
which includes, by the way,
people affiliated
with our competitors,
several of them.
Just to be clear,
I mean,
Kermu said that
a number of people
that he's aware of
have requested access
to the models
and not been given access
and been told to
stop reaching out. And so I do think, I don't know, who's...
Completely, utterly inaccurate and false. There is not one person who has filled in
the nucleus origin type form, which is a type form, fill in a type form that has not
gotten access to our model weights. And by the way, that includes people affiliated with
the competitor. Okay. And so I think what's really important here is the science is public.
The message of the community is go and test it. In fact, our science is public. The
competitors is not. So what I would propose is they should make their science public and let's
have a third party independently evaluate the rigor, equality of the science and let's do it for
everyone to see. Instead of he said, she said, they tit for the tat, you know, put the science
out there, have a third party independently evaluate them. That is my message to our competitor.
We are happy to stay behind our science and we know that it's the highest quality science that can
exist today. But by the way, John, that's not even the point either. You know what the point
actually is? The point is about the patient. It's about having the empathy with the patient so they can
know when they do embryonic selection, they can feel comfortable and confident in the results.
Yeah. And this Twitter back and forth, this tit for tat, this, oh, this person's race changed
on the nucleus landing page, it's ridiculous. Yeah, yeah. It's really ridiculous. And so that's my message.
Speaking of the patients on the landing pages, what about the chronology here?
This idea that there's a review of a baby with three months old, takes nine months and works
with a baby, should have happened a year ago.
Was the service available a year ago?
How do you square that particular allegation that the review, the timing of the review
just doesn't line up with what must have happened in the real world had they used your service?
So there were several claims about the reviews.
Let me address each.
Please.
First and foremost, obviously as a HIPAA covered entity, we cannot disclose patient name,
much less their picture.
If a patient chooses to, they can publicly endorse the company and they can put their name in their picture.
Otherwise, a patient can submit an anonymous review, and then we'll put that according to the landing page.
And so maybe perhaps the people on the Twitter timeline, maybe they never run a company
that involves any protections to the patients.
Maybe they don't know about this.
Maybe in the broader tech community, it's like unfamiliar.
If you run a software company, it wouldn't make sense necessarily.
It does not disclose the patient name.
And I'm going to say to, John, this is really important.
Do you think you have to disclose the fact that you're using an AI generated image?
Is that best practice or is that legally required?
You know, what I think we should do, though, is now that the community gave us this feedback is,
we should update and make it more clear, hey, this is clearly not a real picture.
And this is both not a real name.
That's reasonable.
Okay. Now, fraud, this, that. Guys, really? Come on. Okay, we'll update it. We'll make sure that the picture and also the names are more clear. But again, we're a hippocovered entity. You can imagine when you launch an embryo product specifically, people do not want their name to be affiliated with it. I mean, you have an non-accounts affiliate with these things. Imagine a patient that actually underwent nucleus of services. Yeah. So now regarding the timeline thing. That's the second thing you mentioned. I want to directly address that as well. Obviously, a company like nucleus can start
providing services to patients earlier than we publicly launch a product. Moreover, you would
imagine the services that you provide to patients would be the ones that actually the beta service
that you provide to patients would be the ones that you'd have reviews for, obviously because
they do the services prior to the company actually launching the services publicly. So that's it.
That's the answer. So you were using the service before, maybe a year ago or something, then you
announce the service.
And that's why the results.
We have a question to do embryo analysis probably three years ago.
Yeah.
I would wager that, you know, that actually was probably one of the first times before any
of these companies to actually provide a sort of this sort of services.
So we didn't think about this for a long, long time.
Yeah, of course.
Yeah.
It makes sense.
It's a very logical place to go.
It's also a very competitive industry.
There's a bunch of reasons why you'd want to play in that space.
What about the delta or the perceived gap between the marketing claims?
What's on the billboard?
What's in the New York subway?
I'm seeing 50% IQ, 80% height.
They feel like bold claims.
What's actually possible?
What can customers actually get from nucleus today?
What could they get a year ago when you were beta testing the product?
I want to interrogate the gap there.
So to be clear, there is no.
gap.
Right.
Have a healthier baby.
Have a taller baby.
Have a smarter baby.
IQ is 50% genetic.
Hight is 80% genetic.
These are just facts of the matter.
The latter two are hertability estimates.
They are what they are.
The former two are basically describing what you can do with nucleus.
What I think is interesting here is actually a broader commentary.
Nucleus is bringing the science mainstream.
We are taking it out of the little echelon.
of the rationalist community, the little echelons of the scholars going back and forth
at it out of the Twitter out of the way, and we're bringing it to the actual people who will benefit
and use these services.
I cannot tell you when you actually talk to a patient, not somebody on tech Twitter,
when you talk to a patient, they have no idea this technology exists.
And the first time they're discovering it is when they go and they actually see the campaign
in the subway.
And now I think it's personally good for the entire industry, right, where you actually bring
broader awareness, it lifts everybody, us, our competitors, and makes this actually more and more
into a space. It's very early. My advice to our competitors is focus on serving your patients.
Because at the end of the day, the market's huge, and this market is extremely in its infancy.
And I think they would push back and say the industry can't afford to be sloppy.
And I think that the...
I agree.
I think it's a fair allegation that some of the ways that nucleus materials have been presented have been sloppy.
Do you, I guess one question I have is to think.
What are you specifically talking about?
What has been sloppy?
Specifically, like the reviews, the reviews are sloppy.
I totally understand.
Using an AI image or using a stock image without making it clear that.
This is anonymized because of HIPAA.
If it just said it, if it said at the bottom, there's little asterisk that's an anonymized because
of HIPAA, I think everyone would be like, oh, yeah, that makes sense.
Like, they made a choice.
And I think that's, like, the first thing that I would count as, like, sloppy.
That's fair.
That's fair.
And we're going to update that.
Do you think that, you know, that's proportional to the temperature on Twitter?
I think this is the most politically charged category in technology.
Yeah.
And you can't afford to, you can't, like, basically the industry as a whole, I don't think can afford to make a lot of mistakes.
I agree.
I completely agree.
This is the, this is going to involve the health of all the industry's, you know, clients.
Yeah.
There were allegations, too, that you guys were sort of updated a test result on the fly.
I have no idea if this is true, but I saw the claim going around.
Somebody had gotten a certain test result.
and then it had been updated two weeks later.
Yeah, what's going on there?
What's happening?
That's super interesting.
Nucleus, remember, guys, unlike these other players, we've served thousands of patients.
Sure.
And then we can go on our website right now and use our product.
They can see our services, right?
I mean, I think it's really funny what's flying around when someone can just go and buy a DNA kit and see the product for themselves.
Yeah.
Okay.
So the idea that OB updated a model, we've updated models for last several years.
I mean, results will change.
We make that very clear.
And by the way, any embryo selection company, nucleus is full stack.
We do adult DNA testing analysis.
We also do the embryo and also do a full end-to-end IVF experience.
We're kind of multiple product.
But these models will evolve.
One point here is important John to mention.
People have a very good intuition when it comes to AI that chat TPT is going to be better next week.
GROC's going to be better at two months or now.
The same expectation has to be communicated to the genetic optimization industry.
The main limitation for building polygenic predictors is data.
It's a data problem.
And so what's going to happen is all the different polygenic predictors are going to be approximately equivalent, okay, until we get more and more and more and more data or people get more and more and more access to data.
That is the fundamental bottleneck of the industry.
In other words, similar to actually the AI situation, all the value is going to shift downstream to the application layer.
The reason why, the reason why people are so upset is because Nuclase has excellent science, rigorous science, and we have excellent marketing, excellent product, and we've served more patients than all the companies put together.
And so I think the possibility of something.
But if somebody gets a result and they make a decision based on that, and then a few weeks later, you come in and you say, actually, it was different than what we said, but they've.
ultimately made a decision that they cannot correct.
Is there a regulatory framework?
Yeah, that's a tough.
That's a very tough situation.
Is there a regulatory framework that requires you to communicate to patients that?
100%.
So we're a clear certified, of course.
We're a clear certified cap of credit laboratory.
Any single time of update is made, it would be reflected in the physical report of the
respective customer.
And also importantly, remember, there's a lot of disclosures, a lot of different consents
people have to sign when they sign up for a genetic testing services. One of them is, of course,
that the results can and will be updated. And that applies to everybody in the industry. And that,
by the way, applies to any lab developed test. The tests are getting better as more data comes in.
Software improves. That is the nature of how these things go. That's something that Nuclid has been
very upfront with and we're very upfront if results do update or change. Yeah. Yeah, I'm super,
yeah. I mean, we were talking about like there is a world. And I think this is why the
marketing is really like so important for what you do. There are so many other, uh,
industries where, uh, if, if, if I'm, if I'm watching and if I see a billboard for
Instagram and it says like the most entertaining images on the internet and I downloaded and like,
I'm like, this isn't as entertaining as YouTube. Like I feel like, yeah, whatever, you know,
it's not that big of a deal. Um, but, but the worst thing that could happen is, is I, you know,
someone does nucleus with their, their embryo. It's, it's accurate, but there's a minus sign in front
of everything. So instead of like the tall and smart one, they get the shorter,
dumber one, and then they can never go back from that. And this is this weird scenario.
And so I do think that there's a, I think that you're, you're potentially correct that the,
the temperature on Twitter is, is high, but it is a very high stakes industry.
Very high stakes. I think this is, I think it is appropriate that you will just kind of need to
deal with this for a while. I would love some background on,
this idea of the implications of scores changing.
I feel like that happened with 23 and me.
I feel like that was the promise of 23 and me
was that you do it and then as more data comes in,
you can opt into extra studies.
How did they solve that?
Have you studied that business
or any other previous DNA testing businesses
to understand how to actually wrestle with that issue
of the changing results over time
as more data is created?
So there's a couple things to unpack there.
The first is that you don't want to be a widget.
Okay. Fundamentally, 23 minutes is a widget.
They thought that with their data, they could be able to actually eventually mine drugs,
which because of the limited nature of their data is actually not best for drug discovery.
But on the whole genome front, maybe you could argue, okay, that that won't be a problem if ever a company wanted to do that.
But actually, there's a meta point here about the genetics industry, which is, I think,
and this is, you know, kind of for me, which is I think that too often people focus on the genetic
test. It's not actually about the genetic test, right? Usually people have a very specific acute
problem they want to solve. In the IVF context, it's about, for example, having their best baby.
So you'll see more and more patients are signing up for nucleus to do IVF. And it's IVF that's
full stack powered by our genetic stack. Because what's really unique about nucleus as a business
is because we've done the adult DNA testing, right, for many years now. And then now, we'll
to do the embryo analysis. So we can actually build a new kind of IVF experience called IVF
plus that is centered around giving parents as much information as possible into their embryos.
And notice that shift there, John. You go from being a widget to actually trying to serve a process,
a workflow that exists and that if anyone who wants to have a baby has to undergo.
One thing that Kermew was kind of hammering that I hope I don't botch was something about 12 snips versus a million snips.
Previous data required a lot more genetic information.
You nucleus was making the claim that you could get just as much signal from much less data.
Is that right?
What is your reaction to his take that it would be impossible?
for nucleus to derive such a strong signal about the impact of genetic information from such a
small data set?
My response is, the models are public.
Go check them.
I mean, the models are public.
To be clear, he also said that he tried to get access to the model and that he couldn't, but
you're saying that he's lying about that.
It's a complete lie.
Okay.
It is false.
So it is incumbent on him that he proved that he applied or something like that.
I don't know.
I doubt he took screenshots of his.
I don't know.
I mean,
he wants,
yeah.
I mean,
also,
by the way,
we'll give the weights.
Okay.
Just go,
literally mynuclac.com slash labs.
Yeah.
Go on there.
It says origin,
open weight.
Like open weight.
You know,
instead of all this debacle,
all this Twitter nonsense,
the message to the scientific community,
the message to Twitter is
go check the weights.
And not just that.
Our models are public.
Okay.
Yours are not.
Make your models public.
And we can actually have a conversation then.
What about the allegations of,
of plagiarism, copying from a different paper.
When I looked at it, it didn't look like, you know, I'm not equipped to evaluate if it's a
direct copy or not.
Is it scientific breast practice to stand it on the shoulders of giants and pull from,
you know, what the best research you're doing, even if they're at your competitors,
or with something else more sinister going on?
Or maybe a mistake?
I think the thing to remember is like, you know, a lot of research, like if you think about like
in AI context, right, it's like attention is all you need.
Yeah, they will use that paper.
Yes, yes, yes.
The transport paper has gone everywhere.
It's the same thing.
What are you going to say?
A.
Google stole, like open AI stole it from Google.
Yes.
Come on.
You're not going to say that because it's public research.
And so it actually comes back to the fact that nucleus is bringing this technology mainstream.
Yes.
Our campaign is succeeding in every metric.
Sales are up.
Signups are up.
We have multiple articles covering the campaign.
People are starting a national conversation as we saw on Twitter.
And I think people want to try to tear nucleus down because we have excellent science.
And science, excellent science, is the first step to building a very successful biotech business.
And this is what I think a lot of the armchair philosophers on Twitter don't fully grasp,
which is in order to actually build a successful business, you need to have each and every single one of these components shown.
It's very easy for a scientist that's never actually built a business,
that's never actually tried to sell to a normal person, right,
to say, oh, the marketing is extreme.
Oh, the marketing's over the top.
Oh, the marketing's this.
The marketing is helping a patient identify a genetic risk
that they would unknowingly pass down to their child.
There was a patient recently who they were doing IVF with nucleus
and they identified that they actually had a gastric cancer marker,
a colorectal cancer marker actually, excuse me.
And that marker doesn't just impact their health.
it also impacts their future child's health.
So what do they do?
They chose the embryo without that specific genetic marker,
and they took themselves precautions to make sure that they don't get cancer.
And so that's what Nucleus is about, and we're going to keep serving patients.
Yeah.
Makes a lot of sense.
Sorry to everyone.
We're having a little bit of trouble with the stream.
This has been a fascinating conversation.
I like the gauntlet being thrown down on
the next step here, actually being
let's get the models in everyone's
hands, because that seems to
be a fundamental disagreement here.
You're saying that you'll give them
the model, give them the data, they're
saying that they can't get it. Well, the next
step out of this debate, I think that
could silence a lot of the armchair
philosophers. What? Do you
care about rebuilding
trust with the
broader community on X? Because
Yes, absolutely.
And that's why you can hear. Yeah.
Yeah, yeah. And then I guess like what are kind of the, what are the handful of things that you're committed to doing to make that happen?
A lot of things. One is the AI thing. I think, you know, we should fix that, as mentioned, right?
Make it more clear that it's AI images that people want to be under prex under HIPAA. That's one thing I think we should do.
Another thing is that, and this is originally why we made the models actually public,
is because we need to be more clear that people can go and actually test and check this stuff, right?
In some sense, like, a company can do something, but if people aren't aware of it,
that's also my responsibility as CEO, right?
And so part of the reason is why I'm saying, hey, the models are public, come, submit to get to them,
is clearly there's an information gap there that for whatever reason wasn't filled in my nucleus,
I'm going to have to do better.
And the last thing I think, which is really important is sometimes,
on Twitter, this one personally hurt me.
I, the amount of time we've spent making the product
in a way that people can try to understand
where it shows the error bars, for example,
where you can see that there's signal,
but there's not a lot of signal.
Or in some cases, there might be a lot of signal
with something like height, right?
The amount of time and effort and product design
and science
and sort of like scientific communication specifically.
It's been years.
Nuclid's been around for six years.
I've done this for years trying to get that right.
When you see the embryo on your smartphone,
it's easy to look at that and just write it off.
Right.
I encourage everyone to go on Pick Your Baby.com,
go to them the flow, click around,
look at our disclosures, look at the way we present information, right?
It really is, it takes a lot of time.
It takes a lot of effort, right?
And I think that is something that I'm thinking about,
How can we better put the product out there?
Because I think when people can't see something, when they can't see the product or they can't see the science, then they start ruminating.
So that's what I really, really want to do.
And how do we better kind of connect?
And also, honestly, I think I need to be also more mindful.
I mean, clearly, I inadvertently, I piss some people off.
And that's understandable.
That feedback's taken in.
Okay.
I'll be more mindful because I really, really, really, really, nothing is more important to me than a patient coming.
to nucleus getting the highest quality care in every sense.
Yeah. Well, thank you for taking the time to talk to us.
Thank you for taking the time to break all of this down.
We are fighting through some technical issues, completely unrelated to what's going on.
Somebody didn't want this interview to happen.
Somebody didn't want this interview to happen. I don't know.
But we really appreciate you taking the time to hop on and set the record straight,
give your side of the story and explain what you think.
folks are getting wrong on the various issues here. It's an incredibly detailed and incredibly
important discussion, and we really thank you for taking the time to talk to us.
Thank you, John. Thank you, Jordan.
Have a good rest of your day. We'll talk to you soon. Let's go back to the timeline.
We do have more guests if you are tuning in because of that debate. The chat is active,
but we don't know the status of the stream. The chat is saying,
that the stock is crashing
because, of course,
we're having stream issues.
I don't necessarily think
we got to put this on us.
You know, there's all sorts of, you know,
independent state actors
that have attacked us in the past.
We've had major outages from the hyperscalers.
You know, Nvidia put out a statement
saying that they're not Enron,
but that doesn't mean that they're not somehow responsible
for our stream, lagging in quality.
Who knows?
You have no idea what's going on,
why our stream is having issues.
All I know is that it's not our fault.
That's for sure.
There's definitely nothing that we did.
Rameu says Kian is now dodging the question about the Mendelian disease.
He flagged for a patient and then revised on this is illegal without notifying the patient.
He's saying it's just a model update.
This is not something you update on.
Medellians are definite.
You have it or you do not.
Yes.
Endilins.
Interesting.
Well, we have Joe Wisenth,
from Bloomberg joining. I'm very excited to get an update from him. Oh, he's here. Welcome to the
stream. Thanks for having me. It's been too long. It has been too long. We're sort of fighting for
our life on the stream, but the conversation between us should be fine. We had a very dramatic
debate in the bio context. I don't know if any of this bubbled up to you, but this anonymous
poster, Kermew, is alleging that this company, Nucleus,
You might have seen some subway ads.
Have a healthier baby.
Yes.
Oh, I've seen these.
Actually, I don't know if I've seen the ads.
I've seen the photos of the ads.
And I know that there are the subway stops that I sometimes go to.
Yeah.
But I actually don't know if I've seen the ads.
I'm going to look for one tomorrow morning.
I'm going to go to the stop that I've seen those photos.
I'll take my own.
I'll verify my own photo.
We were joking about this that there's something about New York subway advertising that's like uniquely viral.
And every company.
no matter where they're based, just wants to, they see New York only as a place to run out of home
and then go viral.
Because this has happened a number of times, friend.com.
I'm sure you, did you actually see the friend.com campaign in person?
I definitely saw it.
And without feeling, every single one was vandalized, period.
It was not a single exception.
Really? That's true.
Every single one.
A hundred percent of the ones that I saw are vandalized.
That's hilarious.
Zero exceptions.
They were all over the place.
There was one that it's right on the drive from the gym to our office.
to our studio.
But it's hilarious because it's a billboard
that's directly up against a wall.
So you can't see the full ad.
You just see end.com,
and it just is very ominous,
like this is the end.
And it's clear because the buy was so broad
that they didn't think that,
oh yeah, that one's actually not valuable at all.
I love that.
I love that they literally.
They just spammed real life.
That's what happened, right?
They spammed the physical world.
And it was getting worse and worse.
They were spamming Los Angeles.
and then I live in a suburb of Los Angeles, Pasadena.
And then one day, I'm driving around my hometown, which is very quaint and sort of out of the loop.
It's not the San Francisco hubbub.
It's not teapot.
It's Pasadena.
It's a very chill suburb.
And I see a friend.com ad billboard.
And I'm like, I can't believe you followed me here.
It's following me everywhere.
It follows me on the internet.
Follows me to L.A.
follows me to Pasadena.
I can't get away from it.
It's like clicking on an ad, you know, or something.
And then you just get, you know, served that same ad over and over again.
except this one is real life.
I do wonder if the rage bait, if the, if these, like, because there's these small campaigns
from these like tech startups that are, in one way, you know, I criticize them.
We criticize them here on the show.
But, you know, I think that in some ways these are just, you know, pranksters on the internet.
These are young entrepreneurs figuring out how to get attention.
I'm somewhat sympathetic.
But at the same time, I do see that there are people that make political decisions based on this stuff.
have you been following like the tech lash and all of this, like the data center news?
I've heard, yeah, absolutely.
I've heard of it.
I've heard that there's a bit of a backlash brewing, yes.
How real do you think it is?
And do you think it's going to be more power driven or water driven?
Or slop driven?
I think it's going to be very real.
Oh, slopter.
Yeah, it could be all the, I think it's very real.
I mean, I really wonder who is even in the 20, you know, 2028 or even 2026, who is going
going to run on anything that actually is like, oh, no, actually data centers are good.
AI is an important industry of the future.
You know, actually the power stuff has been overstated.
The water stuff has been dramatically overstated.
I have a hard time seeing any politician actually running on that case.
It seems like anyone, Democrat or Republican, it feels like they almost have to be automatically
against data centers for some reason.
And I think you're right.
Like I think that there's people have some intuition.
They don't like AI companies.
They don't like big tech, whatever.
And then they fill in whatever seems satisfying.
So I don't know.
I think the water stuff seems like the most out there and disconnected from reality.
And so therefore, the people who are most disconnected from reality will probably latch on to the water stuff.
The people who are a little more sort of, I don't know, Normie in their views about how the economy will maybe talk about the electricity.
And then people who just dislike the sort of broader effective tech and all these different.
things. They're probably going to talk about the slop and how it's ruining society, which
maybe it is. I'm not really sure. But it does feel like there's something, to your point,
there's something for literally everyone to latch onto in the anti-AI fight. Anyone can have
their thing which resonates with them, in which case it's hard to see where the constituency is
to build these things. So I think what you end up is probably a lot of entities, you know,
looking for places in the middle of nowhere in Texas where they can set up their own natural gas plant
and their own gas turbines or something
and, you know, stay off the grid
as long as they can.
We got to get a politician who's just like,
you know what?
Like, this stuff's delightful.
Have you seen a studio Ghibli?
I like the studio Ghibli.
I like a studio Ghibli. I like a Suno song.
Yeah, someone will, like, who is it?
Like, just even when you say that, though,
like it's hard to imagine who that politician is
or what the case that they make.
You know, so few people write today.
I mean, I use some AI tool basically every day to look up something.
Who speaks for us?
Who speaks for the constituents?
They do one deep research report every couple days.
And they use the thinking models to answer some questions every once in a while.
And they generate some funny images every once in a while.
And then they kind of move on.
And then they come back to it in a little bit.
And then it's like, oh, they have a new thing out.
Let me, I'll run my battery of tests that I do with every new model,
the questions that I always ask.
It's pretty good.
Yeah, yeah, pretty good.
No, I think it's going to be, it's a real, it's going to be really tricky politically.
I think, and I really think it'll be huge because just to, you know, the labor market is soft.
Yeah.
So here is this, and electricity prices are high.
So, and granted, we don't know what the conditions are going to be in 2026 or 2028.
Yeah.
But right now you have people who are, you know, in the AI industry, obviously many of them, in fact,
talking about the potential for AI to display significant amounts of labor.
who's going to vote for that?
Like, how is that?
Again, I could envision some world in which human life is a lot better when we've been freed from many laborious tasks.
Totally.
But in today or tomorrow or 2026, it's hard to see like what is the thing that gets people excited.
Yeah, I mean, pre-internet, pre-internet, it would have been a lot easier for Silicon Valley to navigate, navigate this tech trend.
this technological cycle because you could have been going to the capital markets and saying,
well, you actually want to give me $100 billion because I'm going to deplace millions of jobs
and all these categories. And we're going to capture some percentage of that. And then you could go
to the everyday people. You could go to the media and say, you know, we're going to create super
abundance for everyone. And there won't be any jobs. And you're going to have an army of robots
that, you know, run your whole life. And it's just going to be this beautiful.
beautiful utopia. And now people go on one podcast and they want to talk about job displacement
and they go on another podcast and they talk about utopia and the same people end up seeing
both of them and it just doesn't, it doesn't work. I couldn't agree with you anymore on this
specific point. No, for real. I think this is like one of the defining phenomenons of our time,
which is there is no such thing is segmenting audience. And this is a phenomenon that occurs
across all sorts of different realms, whether we're talking about politics or Wall Street,
etc. Historically, people talk differently to different groups, and that's just very normal,
et cetera, and you tell one story to someone, if you can't do that anymore at all, everything in any
context is implicitly understood, including internal company communications, right?
Where we expect everything to leak and you expect someone to any memo that you share.
So internal communications can't really have any candor anymore because that all reads as PR,
because that's expected to leave in some part.
And every single person running a lab has had something where six years ago they were on a mic saying confidently,
it's very likely that AI will kill all of us on a long enough time horizon.
And then that resurfaces today.
Or even worse, they'll say, like, one of my worst nightmares is that this happens.
And that's why I'm working to stop that scenario.
And then people just remember the bad.
Yeah.
Yeah.
But this is a weird thing about AI specifically, too.
which is that we're sort of at this point,
where several technologies that maybe we were really excited about
at some point in the past, years down the line,
like, oh, we didn't really think,
this turned out to be not so great,
or we don't really love the effect that this is having out society and so forth.
AI seems very strange,
and distinct from anything else I can think of in memory,
where from day one, even before it really existed,
the people invested in it and sort of working on it
have talked about its downsides
in frequently dramatic, dramatic terms,
such as you're describing.
So it's very different than any other technology where usually the downsides only become apparent years and years after they've sort of suffused and soaked into society.
Here they're talked about from day one.
Okay.
Last week, there were two headlines that I was trying to turn into some sort of pithy phrase or headline.
I couldn't really land it, but I'd love your feedback.
So, Nvidia beat earnings and we got a jobs beat.
And so I was riffing, I was like, demand for robots and humans.
through the roof? Yeah, that's right. Is that what's going on? Or am I misunderstanding the
jobs numbers? Was that less impressive than people thought? The October jobs report is canceled.
Yeah. And the GDP. So the, yeah, I'll say a few things. I mean, that September, that jobs
reports from September. It feels like a lifetime ago. You know, the other thing, too, is that although
it did, the pace of job creation for September did come in higher than expected. Once again,
Job creation was actually negative if you include health care and social care work, which is a thing that I think I've talked about a couple of times when I've caught up with you guys.
But those are the jobs that we would really like to see AI liberate us from, right?
It would be really nice if you could actually have robots, change the bedpans of seniors or other these things that are sort of low productivity jobs, jobs that for many people are low paid, kind of miserable in many cases, et cetera.
So I think what's going on, unfortunately, is that we're in this environment in which job creation overall for most sectors is pretty mediocre, including finance, including tech, et cetera.
The one thing that keeps powering us forward are these sort of menial, low-paid jobs in health care, service sector, taking care of seniors, et cetera.
And I don't know.
It feels like we're very long, very long until anything AI-robot-related is actually getting into that sector.
But that would be the dream, right?
I mean, that's what, that would be the dream to make progress in that front.
I mean, elder care was the original pitch of Honda Asimo back in like 2000 or 1999.
It was like, yeah, this robot's going to bring the meal to the old person in the sick bed.
Wouldn't that be amazing?
Makes a ton of sense.
And there are, to be fair, there are some robotic, like, you know, with wheels on it, rolls around, does some stuff.
But certainly not broad deployments by any means.
Yeah, not broad deployment, not at the scale.
And so what happens is we have this economy where, you know, the unemployment rate is still pretty low by historical standards, although it's gone up a fair amount a little bit in the last year.
But there's just so much pressure being put on the existing labor force to care for the aging population.
It creates some pretty serious strains.
Yeah.
How have you been tracking the, just the AI spending bubble, this idea of, you know, massive growth, debt coming into tech for the first time in a long time.
in a long time. I feel like a lot of tech people are so used to the venture capital model.
Okay, yeah, it might be $100 million at risk, but this is, you know, 1% of overall allocation.
There's a bunch of LPs from foundations. It's very diversified. And if that company goes bust,
that's fine because another company is going to do great. Now we're looking at serious numbers.
We're getting into trillions. There's debt involved. People don't know how to manage with that and
deal with that. How are you processing it? It was sort of a real wake-up call to,
me when I started seeing people online post screenshots of credit default swaps on Oracle debt.
Like that was the moment where it was like, oh, this really has transformed from the sort of
equity funded, free cash flow funded environment, which is characterized tech for, you know,
over two decades, really going back to until the telecom bubble.
So as soon as you, and I know these companies have debt.
I mean, you see them.
Apple has debt.
They've had it for a long time.
A lot of these debt issuance, though, in recent years.
have been more less like exercises in cash flow management or optimizing taxes and stuff like that.
Now it feels like, okay, like this debt is at a very real scale where I'm looking at core weave credit to fault swabs, Oracle credit to false swabs, etc.
That is to my mind a signal of, of course, something's changing.
Blue Owl, they're publicly traded.
That's the private credit company that's gone in with a meta to do some data center financing.
That stock, I think, has become a bit of a proxy for how people perceive some of the financing risk in that space.
The deal that – we have an episode coming out, I think sometime next week, actually, where we talk a little bit about how the credit construction of these events.
The founder of this company, Noetica, which uses AI to examine credit agreements actually walked us through it.
It's some fascinating stuff, but people are sort of looking at it.
it, okay, who is the real bag holder here?
What is the risk of, you know, people are talking about, obviously, what is the risk if there's not as much value in these GPUs five years from now as we may have thought?
And to your point, that's just totally novel for tech in recent years.
It doesn't feel like we've, it's been so long since the idea of debt or leverage in that way has been part of the tech story.
Yeah.
What did you, what did you make of Nvidia sending out that report for the sell side over the weekend?
And then again, they had another post.
They had another post today.
I'll just read it in case anyone's just tuning in this morning.
Let's see, we covered it at the beginning of this show.
We're delighted by Google's success.
They've made some great advances in AI,
and we continue to supply to Google.
NVIDIA is a generation ahead of the industry.
It's the only platform that runs every AI model
and does it everywhere.
Computing is done.
NVIDIA offers greater performance.
versatility, fungibility, than A6, which are designed for specific AI frameworks or functions.
So, again, not, like, these are, these are meant to be confidence-inspiring, but they come off the, you know, they have the opposite effect.
It's really weird.
The tweet, like, I guess I sort of understood, okay, so they sent out that note, you know, look, as I mentioned, over the last several weeks, for some reason, Wall Street has got really taken in with this whole conversation about GPU depreciation schedules.
Maybe I think Michael Burry's been talking about it or something.
Okay, fine, like this has taken hold.
I am sure this is the type of thing where for every hundred people who are talking about this,
maybe one knows what they're actually talking about.
Like, I have no doubt that there's all kinds of noise out there.
And so maybe it makes sense for Invidia.
They're like, oh, let's put out some information that we have.
Like, I guess it's a little weird, but okay, like I sort of get it,
given the degree to which this has just become a meme in the last few weeks.
the tweet about Google is a little strange.
Like, I typically...
Here's the biggest, most powerful company in the entire world,
and they're doing this sort of weird.
We're excited to see, we're happy for your success.
It reminded me...
It reminded me of Jensen's comment on the OpenAI AMD deal
where it was like minus snarky.
He was saying something like,
I'm kind of surprised they would...
They're so excited about their new chip.
I'm surprised they would give away 10% of their company before they've even developed it.
So, again, to me, I feel like when you're operating from a position of strength and confidence,
you never talk about competitors from official channels.
In fact, I've given this advice very recently where, like, there's a company that every time their competitor does something, they post about it.
guess the revenue difference.
Like a quote tweet too.
It's so much easier to just be like our esteemed,
the other members of our industry or like the other big tech companies do it this way
or like other handset makers or other smartphone makers.
And everyone knows that you're talking about Google or iPhone or whatever you're comparing to.
But in this case,
in this case the company that they always talk about has a hundred times their revenue.
And so it and so it screams like,
It screams like we're obsessed with our competitor.
But in this case, it's like the TPU is just like the first sign of an external.
Right.
And you immediately like pounce on them.
And you're like, you know, I've been thinking.
I mean, one of the funny things about Jensen and Vida overall is you think about these other mega-cap tech companies and these other ultra-rich CEOs.
You know, they've been dominant in most of these cases for like well over a decade.
right now. They've been some of the most powerful companies in the entire world for over a decade, obviously.
Invidia is sort of this weird case because, you know, four years ago, people were talking about, oh, this is the company that makes chips for Ethereum mining.
Or this is, like, that was how a lot of people talked about in video. I think even as, yeah, as recently as 2021 people were talking about, oh, NVIDias.
So it might be a little. Well, people don't remember before there was the Mag 7, there was Fang.
And there was an end in fang.
And that was Netflix.
It was Netflix.
It was not Nvidia.
It was Facebook, Amazon, Apple, Netflix, Google.
And then crazy to not include Microsoft, right?
And so they added Microsoft and they took out Netflix and then they added Nvidia and Tesla, of course.
But yeah, I mean, what a wild drive for Jensen.
Like, what a run.
I mean, obviously, like, a VIDIA has been an incredibly successful company, but it went from like a pretty successful ship company to the
the biggest company in the world in a matter of few years. Maybe there's something there. Maybe
there's still a chip on the shoulder. Maybe there's still some culture of feeling like it's the
underdog and something where it's like, yeah, it's like act like you've been here. Yeah, it's one thing.
The tenure thing is real. So here's the thing. If you're a startup and Google enters your market,
I've seen a lot of founder or like a big company. If you get Sherlocked by Apple, you're going to hit the
timeline and be like, I'm delighted by
Apple's new
mobile app. We're delighted
to continue serving. They validated the market.
Thank you for, thank you, Apple, for validating our industry.
Yeah, yeah, yeah, yeah. But I don't think
at this case. Invidia doesn't exactly
need validation at this point
from a competitor. And the TBI is a decade old, by the way.
Right, it's been around for a while.
Right, and all, like that, which
is another sort of interesting dimension
of all of this, which is like,
Suddenly people wake up and, oh, it's not like, to your point.
I mean, people have been talking about the existence of Google's TPUs for a long time.
Obviously, now there's been some question about the degree.
What's the strategy here?
Would they ever sell them?
Will they rent them out there?
There have been, obviously, questions, et cetera.
But it is funny how, you know, you get these moments where suddenly, you know, you get this 180 over the last several months weeks on Google, the Gemini three launch, of course, bolstering this idea.
Oh, actually, they're in a good space.
And suddenly, oh, and they also.
have these TPUs, which they've had and been working on for a long time, but nothing really
changed. They've had them for a while. There's not some new breakthrough announcement here
or something. And so suddenly, InVIDIA feeling like it has to respond a little strange.
Yeah, yeah. I mean, it, like, I do think that, like, there's so much demand that it's a little
bit ridiculous to just be like, oh, and VDivis is completely over. But at the same time, like,
it's never great when you go from a monopoly to a duopoly. Like, it's just that, like, it's always
nice to be in a less competitive market.
Yeah, but at the same time,
it's like if AI is literally half as transformative
as the AI Bowles thing, it doesn't matter.
Like, you can have two players,
and the demand is so overwhelming that.
And, like, Nvidia's own sales are capped, right,
by capacity and by production capacity.
There's only so much, which is another sort of,
like, interesting dimension
that I'm, like, trying to get a better understanding,
of here, which is that, you know, again, it's not like search or AI or chatbots, et cetera.
There is the, there are these constraining effects on the markets from how much fab capacity
is at TSM or how many, some of this underlying equipment.
So the ability of anyone to scale up dramatically and expand the overall size of the market
is sort of tough at this point.
I don't know exactly what that means, but it feels like my guess is, my assumption, I don't
would be that everyone remains pretty capacity constrained for some time.
I don't think there's like tons of chips laying out there for the taking right now.
Yeah.
Give us an update on odd lots.
People have been congratulating you on 10 years.
Did the 10-year date happen recently?
The 10-year date did happen.
We didn't even, you know, it's funny.
I think it was November 6th.
I got an email.
November 6th.
So we have a party, which you both are invited.
We have a party in New York City in December to celebrate our 10 years.
So we've been sort of, that's right.
You play the night vision sound.
That's right.
Fire me up.
But so we were getting ready for that.
We've been doing some sort of 10-year episode.
We're talking to some big names and, you know, big, big picture thinkers and stuff like that.
But I didn't realize the actual date until the morning of it.
And I started getting random emails from people inside the company congratulating me, congratulating us on a 10-year-old.
But it's pretty crazy.
Let's hit the gong ten times.
Yeah.
Ten times.
Wow.
Ten times gone.
There we go.
This has been the highlight, the ten gong smashes.
This has been the highlight so far of our ten-year anniversary.
Who's the most recent ten-year guest that exemplified that bigger picture thinker?
Yeah.
Well, we had Ray Dalio on the podcast on Monday, which was a lot of fun.
He told us about meditation.
He talked to us about.
the importance of transparent culture, about the importance of letting junior staffers or junior
employees at Bridgewater attack the senior employees.
I loved his story about the first stock he ever bought.
I know, I know.
hilarious.
I don't know if he tells that constantly.
I haven't listened to every possible.
He probably does.
He's just like, he's just like, I saw it and it was the cheapest stock he could possibly buy.
He was the cheapest nominal stock.
It was like $5 a share.
Yeah.
These retail, it's a retail army.
I mean, it's like in crypto when they're like, it's zero, zero, zero, zero, zero, one cent a token.
Imagine if it's a dollar and you'll be like, I have so much money.
Can we talk about that for a second?
It's really annoying with some of these crypto prices to have to like squint and see how many zeros there are.
They need some reverse splits, I really think.
Like we need to like $1, $2.
But no, to your point, right?
It's basically if we're, I don't want to be insulting, but it's basically like the dumbest.
it's trying to attract the dumbest kind of traitor.
There is when you're like, oh, this is cheap because it's one, one millionth of a cent.
You're still early.
Yeah, I mean.
Imagine if this were a dollar.
I remember the doge to a dollar campaign.
Everyone was a doge to a dollar.
That was a very powerful meme.
It was very powerful.
These things are real.
I thought it was going to get there because I think it got to like 30 something cents.
So I was like, oh, it's definitely going to satisfy the meme.
It never made it.
You're like, I thought it was going to get there because I put my whole page on it.
I really thought it was, I was like, oh, it's obviously going to go to a dollar.
It did seem like the meme was going to work.
It got close.
It got close, yeah.
It was in the run.
Jordy?
Are you aware of a single person that has sold their primary residence in New York
and is going to, going elsewhere since the election?
What's been the sentiment?
I know a bunch of former Oddlott's guests that are on the transition team.
Are on the, yeah.
Which is cool because you guys have some insight into like how these,
people think and the public does.
Yeah. I have not heard
of anyone who is leaving
New York City. It's interesting.
I don't know the name of the brokerage,
but there is one of the brokers
in New York runs these ads,
speaking of outdoor ads, in the taxis.
And prior to the election,
they were very scaremongery and they were like
talking about deals in Florida
and all this like real estate you could buy
in Florida, etc. Anyway, after the election,
I saw one of the ads this week,
and it was talking about how J.P. Morgan
just opened up its new headquarters in New York City and how all of the how many
employees they're going to have there. So I guess now that now that the election is over,
they can go back to selling New York City real estate because they didn't get the,
I don't think they got the out. Those brokers did not get the outcome that they were hoping
for. But yeah, we have some, we have some past guests in the transition team.
Paul Williams, shout out to him, who I also play music with in my country music band,
light sweet crude. He's on the housing transition. Kathy Wilde, who is the head of the partnership for
New York City, which is the big organization of a bunch of CEOs, et cetera. That's like the most like
died on the wool, like sort of, you know, they're not a lobbyist group, but they represent the
business community. Even she is in the transition team. She's also been on the podcast. So it seems like,
you know, I've seen a bunch of people angry at some of the picks, happy about some of the other
picks. It seems like he has built
a, um, he's a, uh, at least with
these selections, a little something
for everyone, some moderate, some
normies, some more radicals, etc.
Enough for like everyone to be a little happy
and a little, a little concerned maybe.
Yeah, yeah, I mean, it certainly seemed like that,
there was that violent clip of him with, uh, Trump that was very
funny where they're kind of going. Oh, that was crazy. Yeah. It felt like
there was just like, okay, there's a lot of theater on both
sides here. They're both, they're all having fun.
You know, they're not like, I can't even be in the same
room as that person. No. So, you know,
I think that like for those of us not in politics, I don't know.
It's like hard for us to imagine how these people who are like the way the rhetoric and then they like get together and they smile in front of the camera and like feels very weird.
But you know, they're just like they're professionals.
I mean NFL teams have rivalries.
They shake hands at the end of the game.
That's right.
That's kind of the nature of these things.
Which is fun.
Yeah, WWE.
Yeah, WWE.
I've always liked the wrestling metaphor.
The thing is too is that like whether we're talking about.
the selections of people for the transition or the, I think, very wise choice by
Mom Doni to, like, try to be friendly with the White House or at least find some common ground
is, look, there's some, like, pretty hard budget constraints, et cetera.
The mayor, the job of mayor is a management job.
You know, the trains aren't going to run themselves.
The buses aren't going to run themselves.
The apartments aren't going to get billed.
So there's a certain amount of, like, required between the budget constraints and just
everything else, I think there is a certain amount of sort of forced pragmatism that's probably
at play here.
Yeah, that makes sense.
We'll let you go in just a minute.
All right.
What's next on the economic calendar that you're tracking?
What should we be looking forward to through the end of the year?
Obviously, in our world, we're very excited about Black Friday.
You're going to be tracking those numbers.
Also an interesting economic indicator.
But what's on the top of your mind?
You know, I think actually like basically all data through the end of the year is going to kind of be garbage because obviously we're going to get the restart of the data and we'll get more timely jobs data and so forth.
But all of that is going to be affected by the shutdown.
October, we're not getting anything from October.
Yeah, we're not getting anything from October.
And then November is going to be affected in large part from the shutdown.
So those numbers aren't going to mean anything anyway.
And so probably the next clean report where we could say, okay,
this is actually well-collected data to the extent I need data is there's all kinds of issues with collection and is not affected by the shutdown.
So that's going to come out in January about December, which is going to be very strange.
You know, I think the big development is so I think it's December 10th is the next Fed meeting.
As recently as a week ago, it was looking like they were not going to cut.
The odds were below 50%.
But a number of the FMC members in the last several days have come out and said they're cool the cut.
So it looks like as of right now, we're going to get.
get it cut. But that is, I think that meeting is the day before we get the November
jobs data. So it's all going to be sort of a mess, I would say, until early next year.
Last question. How should people read into not getting data from the month of October?
Should we say that, like, the simplest explanation is employees were furloughed. We don't have,
we don't have time to go back and collect all the information. I think in this, I think my impulse is
that the simple explanation is the correct one.
That due to the timing of the shutdown, the duration of the shutdown,
it's like unrealistic or something like that,
as opposed to something nefarious.
If there continue to be more things, then, okay,
then we see what's up.
But I would say this is probably pretty straightforwardly linked to the fact that,
you know, the government shut down, yeah.
I'm also going to tell you about fin.com.
AI that handles your customer support.
the number one AI agent for customer service.
Our next guest is Director Michael Kratios.
He is the 13th Director of the White House Office of Science and Technology Policy,
and it is great to have him here with us on the show today.
One of the best call-in setups we've seen.
You look fantastic.
Thank you so much for taking the time to talk to us.
How are you doing?
I am great.
Thank you guys so much for having me.
I have followed your meteoric rise over the last year.
I feel like I should have been on this show much earlier.
Yeah, we would have loved to have you, but we're very happy to have you today because there's massive news, but I'd love for you to introduce it and actually set up the conversation. So please take us through the announcement and then I'm sure we'll have a ton of conversation and questions to go through.
Yeah, so I think maybe we can start with the AI Action Plan that the president signed out in July of last year. And one of the main themes of the AI Action Plan, essentially to win the AI race, is all about how we can work.
win in scientific discovery. And the question was, like, how do we do that? What's like the next
chapter of using AI to drive scientific innovation in our country? And yesterday, the president
signed and executive order launching what is known as the Genesis mission. And I think for a lot of
folks that, you know, you guys talk to every day, you know this. You know, AI has, you know,
had this incredible rise over the last couple of years. It ultimately started first with large
language models themselves. And those were where we scrape the totality of knowledge on the internet.
able to then create these models that can predict all sorts of things, the next word, if you will.
The next phase of it was all around coding, and you've seen these great startups that are
incredible of coding. Some of huge model builders are awesome at coding too. But the big question
that still remains is how do you apply this large language technology to scientific endeavors?
How do you use it to be able to create new materials? How do you use it to create new microprocessors?
How do you use it and tap it into all of sort of this exquisite scientific technology and hardware
that exists all around the world. And what the Genesis mission tries to do is to bring all of the
super valuable, important data that the national labs have collected over the last 70 years
and put it to use to train large language models to be able to dramatically, and I mean
dramatically accelerate the pace of scientific discovery. So this is, I would argue, and I've said it
before, and I'll keep saying it, this is going to be the single largest marshalling of the federal
resources of scientific discovery since the Apollo program. So we're thrilled to kick it off,
and DOE is going to be the home for it. Talk to me about the relationship between the public sector
and the private sector. I feel like a lot of folks in our audience have said, thank you for your
service. We loved DARPA. We loved when DARPA created the internet. We love GPS. We loved the
moon mission, but we got it from here. We invented the transformer at Google. We invented SpaceX and
the rockets that go up and land. And we think, uh, we think, uh,
private industry has it handled from here on the research side. We don't need anything from the government.
How do you think about, is that just, is this just a misconception and we actually need more original new ideas, research in a government setting?
Or is there more of a public-private partnership that you think will play out here?
I think it's definitely more of the latter. I mean, the reality is that when some of the initial projects were launched in the 1950s, you think of a Manhattan project, that was an era where the vast majority of research,
in the United States was paid for and funded by the federal government, to the tune of almost
70 or 80% of it was funded by the federal government. If you zoom ahead sort of the 70 years that we are
where we are today, the vast majority has done private, private sector. Generally, the United States
spends about a trillion dollars a year on R&D, and about 80% of it today is done by the private sector.
Now, that being said, there is a critically important role for the government to play in that
larger ecosystem. And it truly is an ecosystem. You have to have private sector, academia, and
the federal government all working hand in hand to sort of make the very important basic research
breakthroughs and ultimately commercialize those. And the secret and the sort of unique special
thing about the Genesis mission is the scientific data sets that exist at the national labs.
This is a unique asset that is so valuable to the American people and to all of a scientific
enterprise in the United States. And the bottleneck, because you guys know so well,
and so many of these AI endeavors is,
how do you get the right data to train these models?
And for the early large language models,
the data was just out on the internet.
You could use common crawl and scrape it.
For the world of coding,
you had lots and lots of coders
and lots of material that you could use
to train those coding models.
But for science, it's not that easy.
You have silo data.
You have pharmaceutical companies
that have pharmaceutical-related data.
You may have chemical companies
that have chemical-related data.
But what's so special about our national lab ecosystem
is that it covers such a diverse and broad range
of scientific endeavors. You have biologists, you have material scientists, you have chemists,
you have people who are working on space all in the same national lab infrastructure, and that depth
of data is so incredibly powerful in order to accelerate scientific opportunity and endeavor.
And kind of that's what the Genesis mission is all about. And to your point about private sector
involvement, the thing that we have been so excited about is the private sector is clamoring to
be part of Genesis mission. We all are in this together. There's a desire to pair the incredible
super computing infrastructure and the GPU capacity of our greatest chip companies with the great
data sets we have a DOE and everything in between.
Yeah.
The, can you help me understand a little bit more how a lab might actually plug into the Genesis
mission?
Because we've seen a lot of the labs say, oh, we want to start working on science.
Some of the labs have already.
I mean, Google is a Nobel Prize, right, for AlphaFold.
Does that, does that look like them interfacing directly with the DOE?
or going through a lab?
How does that take shape, do you think?
So what DOEs ultimately,
the Department of Energy is going to be creating
is a platform for scientific discovery.
And there we're going to be making available
the very valuable scientific data sets
that can be used to run these large language models
for science.
And as we've seen, OpenAI had a nice tweet thread
about sort of this project
and how excited they are about it.
We've seen lots of other companies
already pursue this.
Google, of course,
with Alpha Fold and the Nobel Prize that they've won there.
So what we're seeing is all of these large language model builders or labs themselves want to
partner with the Department of Energy so we can work hand in glove to accelerate the scientific
discovery.
The key is how do we, you just zoom out a second and think about it, how do we 2x the ability
of us to very quickly iterate on scientific experimentation?
So right now, if you have a hypothesis and you want to test it, how do we make that two or even
10x faster?
How can we make it so that if we have an idea, we can send that idea to an AI-powered cloud lab.
And the test can be run behind the scenes as we're working on a second project.
So that's this sort of like big level thinking that we want to do to dramatically, dramatically,
dramatically accelerate the velocity and pace of scientific discovery.
Can you help me understand how you think the United States is positioned geopolitically
against our near-peer rivals on the issue of AI in science?
I'm pretty, I feel like I'm relatively up to speed on just the general capabilities of American image models versus maybe Chinese image models or Deep Seek versus GPTOSS and the LAMA models. I kind of know where we're standing in just the general industry, the industrial uses or the general uses of these LLMs and the AI models that are coming out of America and China. How are you thinking about America's competitiveness on the science and research side?
So we're in a lot earlier innings of that.
That's a really good question.
And I think what's unique about sort of AI for science is it has to pair this exquisite scientific physical infrastructure with the models themselves.
So if you want to drive scientific discovery, you have to be able to pair what's coming off of telescopes, what's coming off of lasers, and all this stuff, to be able to match them with large language models, to be able to accelerate that loop.
And we're still in the very early innings of it.
And in order for us to sort of outpace and continue to keep our lead like we do have in some of these other places is we have to do something like the Genesis mission.
We have to wake up a country and say, like, look, where do we have the most valuable scientific data sets?
And how do we make those data sets available to our model builders to be able to create the necessary tools to pair the data coming off these scientific instruments back into these AI models?
And like, think about it.
For us, we want to win on Fusion, for example.
So for Fusion, Google's already doing this, but there's a ton of companies around the United States that are very heavily funded that all have lots and lots of experimentation they want to do with these fusion reactors.
The ability for us to be able to accelerate the modeling of that through the Genesis mission rather than each individual company having to do on its own can be really, really dramatic.
So back from a pacing standpoint, I think the U.S. has all of these amazing instruments. It has the labs. It has the great private sector together.
And what the general mission tries to do is bring that together in a way that's like truly American,
where each of us as part of the ecosystem can play the important role that we're best at
with obvious sort of commercial goals in mind down the road.
And that's what's sort of driven this great discovery we've had for years.
And I think we're going to continue to see that in the years ahead.
What role does academia play as part of this project in your view?
So I think for us, academia has always played a very,
important role in pursuing early stage, basic, pre-competitive R&B. As we think of all of the
most critical areas of scientific endeavor, whether it be in materials or in chemistry or in mathematics
or in physics or science, there is still a critically important role in that early stage discovery
science. And academia can play a very important role there. They're the ones that have these
these these these these these theories and these ideas, these hypotheses to solve some of these very
early fundamental problems that can ultimately unlock great commercialized solutions in the years
ahead. So academia and universities are and do want to be part of the Genesis mission. There's an
important role for a lot of these departments, professors and thought leaders to be part of it
and to introduce their ideas and concepts of things that they want to test. What ultimately
Genesis is going to do, it's going to create up to 20 grand challenges on some of the biggest
scientific problems we face today. And we're looking for everyone. You can be in academia, you can be in
the private sector, you can be in your garage, wherever you are. We want you to come with the
best idea on how to solve those and be able to leverage a great infrastructure that the federal
government has at its labs to solve those. How are you thinking about AI risk these days?
I feel like we've been on a total roller coaster from sci-fi paper-clipping scenarios to some very
real geopolitical competition and issues with people maybe using these models too much.
going somewhat crazy.
There's been a wild ride
that I think everyone's been on
and I'm interested to hear
how you think about
AI safety these days
is the nuclear analogy
the most important?
Is this a Manhattan project?
How do you think about
the role that the U.S. government
should play in the AI safety discussion?
Yeah, you know, I think as I kind of look back
and think about how the early conversations were
when some of the big model lab builders
came to, you know, came to Capitol Hill
and, you know, talked about wanting to create kind of an IAEA for AI.
I think it, I think honestly, it set the wrong tone,
and I think it set sort of the industry back for a while.
And I don't know how much you guys track sort of like global politics of AI policy.
But for a good two years there, I think that sort of discussion on the global stage was,
you know, what are the worst possible things that AI could possibly do for the world?
And let's try to, like, figure out if we as a collective, you know,
world can find some sort of like global solution to solving it. And obviously that's kind of the wrong
approach. And everyone's backed away from it. You know, the UK themselves that were kind of touting
their big, you know, UK Safety Institute have renamed it, the Security Institute. We as the, as Trump
administration, you know, renamed the AI Safety Institute or Department of Commerce as well and kind of
moved in a direction of innovation and adoption versus sort of this nebulous catch-all safety term.
But I think to me, one thing I always think about, and we always have to balance is, and maybe it's a little personal, but to me, I recently became a father in July. And I think a lot about the way that my child is going to grow up, the way that he is going to interact with this particular technology, the way it's going to impact not only the way that he grows and learns in school, but also the types of job that he's going to have and how he's going to enter the workforce. And I think there are very credible and real things that the American people are thinking about, about how this technology can be best used to improve
their way of life and ultimately help them live a better and more fulfilled and more rich life.
And we at the White House are all about finding ways to encourage adoption of this technology.
And in order for that to happen, we have to have the trust of the American people.
And trust is part and parcel of everything we're trying to do.
Whether we're building out AI for educational reasons or to improve the amount of energy
that we have in the United States or solve the biggest health crisis that we may encounter
in the future, we want to do.
to build that trust. So when these solutions are coming about because of AI, it's embraced.
And it's something we worry about and think about a lot. And it's something that a lot of our
standards agencies are thinking about, how do you promulgate the right standards so that
when these technologies are put into all these different industries, people trust them.
How are you thinking about job displacement at this point? The models are so incredible.
They're smarter than me at everything. And yet I haven't actually been able to drop them in as a
coworker right next to me.
Every day, we try to replace Tyler.
We say Tyler, replace yourself.
He's just too good.
But there's still, like, an ambient level of anxiety that something's coming.
And so I feel like you do need to be prepared.
You can't write it off entirely.
But I'd be interested to hear about how you're thinking about the goals that you could
even set around transitioning people through jobs.
How you think about the AI job relationship?
There's a couple of things.
The first thing is about AI education.
We have to prepare the future American worker to be able to fully leverage this technology
when they enter the workforce.
The president signed an executive order in April of this year where he prioritized
K-12 AI education.
The First Lady has gotten very excited about this endeavor.
We're running something called the AI Presidential Challenge, which is a challenge that we're
rolling out across the entire country where we have students from all 50 states,
participating in it, and ultimately is going to culminate in a sort of competition here at the White House
and at the end of the school year where we can show kind of how students are using AI to solve
some of the biggest challenges they face in their local communities. It's like the presidential fitness.
I used to have to run a mile and touch my toes. And now you have to use AI effectively.
Now you've got a program that's an AI. Exactly. Exactly. That's actually great. That's so good. The presidential
vibe coding assessment. But I do think it's important because at the end of the, and I think, I think the velocity of
change that you see in how education is thinking about AI is so interesting to me. It's kind of like,
and if you guys even remember, like, two years ago when chat GPT first came out, every university
out there was essentially banning it. You weren't allowed to use it. You were like, you know,
violating the honor code if you ever like turned on chat GPT. And now there's no college student in the
country that doesn't use it. So I think that the pace of change in how these models are being used
in education is just so, so dramatic. And we have to get in front of it because, you know,
what we think, you know, an eighth grader is going to be doing with AI when they enter the workforce,
you know, it'd be very, very hard to predict.
So what we try to do mostly in the K-12 space is not necessarily teach kids how to leverage this technology,
but teach them about how the technology works.
The term that was used in the executive order was demystified.
This is really important.
Like teaching both children and teachers, like where does it work well?
Where does it not work well?
Why is it answering questions like this?
Why does it hallucinate?
Why is it not hallucinate in these cases?
You know, and I think the more people understand the technology they're dealing with, they'll be able to leverage it much, much better no matter where they end up in the world.
Yeah.
I absolutely love that because I feel like the, I mean, we talked about this, the GPT psychosis thing.
There's a very big difference between understanding that what you are chatting with is a robot, is a bunch of math, and just being mystified by it.
And the same thing with, you know, at some point every parent needs to teach their kids that, hey, the explosion in that movie, they didn't actually be.
blow up the house. You know, they didn't act. That's a cartoon. And now you also have to do that with
AI generated images. Something I noticed. Yeah. This was a major AI related announcement,
did not have a, I searched Command F for a dollar sign. Well, didn't find it. Is that,
is that intentional? Is that like part of, part of your focus of, hey, the, the government can
catalyze the right sort of like progress and activity without just being a capital provider? We've
seen so many, you know, announcements from this year that are really just fixated on the biggest,
you know, the biggest number. And this feels like unlocking the sort of potential within the
existing ecosystem that's not being properly utilized. Yeah, for the Genesis mission,
I think Congress actually appropriated some money to the Department of Energy this summer and some
the legislation that passed to drive some of these AI-related efforts. And we've used that as kind of
the down payment on kicking off this program. I think what you're going to be seeing in the next
couple of weeks, which we're really excited about, is commitments from a number of large private
sector players on what they are contributing and donating to the Genesis mission. And I think
what's key here is that what makes the American innovation ecosystem so unique is the ability
for us to bring all piece of the ecosystem together to drive innovation. You have one part
academia, one part private sector, and one part federal government. And the reason why, and the feature
about the U.S. innovation system that allows us to be so successful and have been the home for the
greatest scientific and technological breakthroughs for the last 200 years is that free market approach
innovation. And I think that's what the Genesis mission brings together and sort of highlights
in the best way possible, that we are in this together with all pieces of the ecosystem working
together. There's been a lot of worry about going too far, doing too much AI, too aggressive
about the buildout, too much debt. There was this back and forth about the backstop.
David Sachs, of course, said, we're not considering that, but have you thought any more about
what the role of the government is in moderating the amount of sort of private sector AI
build out and how that should even interface with the government at all?
What is the framework that we should be using?
I think we are very focused on removing federal barriers to folks that want to participate in the AI revolution.
And for us, what we see is that if private markets and if capital markets are allocating dollars in a direction that say,
look, we believe that we will be needing this level of compute to drive our future AI demands,
we want to make sure that the bottleneck to that deployment isn't some federal rule around permitting and allowing these things to be built out.
I have faith in the way that the capital markets are allocating dollars right now, and I leave it to those capital allocators to make the best decisions possible for that capital.
What we want to make sure is that we are not an inhibitor to innovation.
Some arcane rules about how and when you can build some certain facility in a particular place are not the reason why the data center we really need isn't built out.
And that's kind of, that's the role that I think the federal government plays.
And one of the three executive orders, the president signed the day that the action plan was released was all about this.
How do we get the federal government out of the way to allow the build out of these as quickly as possible?
Yeah.
What about the, like, going deeper in the stack.
Obviously, there's been news around Intel.
There's a very rational reason to understand a proper,
prioritize, you know, having American control of the entire AI stack. How is your thinking evolved
on just this idea of having a full control over the supply chain in America? Is that something
you're spending time on or you're thinking about or your thoughts have evolved on?
We are. I mean, it's so critical. Back to the great day in July when we signed all of our
executive orders, the third executive order was all about exporting the American AI stack.
And I think, you know, we rewind, you know, into Trump One when I was the CTO of the United States at that time.
One of the challenges that I faced was traveling all around the world and trying to convince governments that they need to rip and replace their Huawei infrastructure.
And at that point, you know, I think there was a big lesson learned by me and by a lot of people who served in 45 about, you know, what are lessons learned from that experience?
You know, in that moment, the PRC had a technology that was good enough and was priced very reasonably, whether it was for a subsidy or who knows what, but it was priced reasonably enough where everyone wanted it and an ultimate was deployed for a big technological shift with 5G.
Now, if you fast forward to where we are today, this next phase of AI is orders of magnitude more important than the 5G rollout.
Right now, governments all around the world in very few short years will all be running some sort of AI stack.
They will be having some sort of chips that will be running some sort of large language model.
And on top of it, there will be important, critical national applications, everything from the way that hospitals are running to the way the tax is collected.
and we want to make sure that the U.S. is the partner of choice for that AI stack.
And right now, we're at a great spot.
We have the very best chips in the world, and we have lots of them.
We have the very best models in the world, and we have a competitive ecosystem that
it seems like every other week they're leapfrogging each other.
And then on top of that, we have the best applications in the world.
So we are so committed to exporting that stack.
We want to create something that is so compelling and so exciting.
for governments and people all around the world
that they will want to use our technology.
And that's what we are building here at the White House,
our partners at the Commerce Department,
and at the State Department,
to get that exported all over the world,
from South America to Africa to Asia,
to anyone who wants it,
because we believe that the same benefits
that all Americans are going to realize
because of our great technology,
we want to share that with the world.
Yeah.
Final question, a little bit of a wild card.
I'm curious, are you thinking about humanoids as a category?
I've been really concerned that we're going to repeat what happened with DJI,
where we allowed a company to basically destroy our domestic industry
and flood the country with cheap, very good drones, but cheap drones.
And I worry that, you know, I think you can buy a unitary robot on walmart.com right now.
It's not a concern today, but if we allow the country to be flooded,
I would be very concerned about it in the future, and I'm curious if it's on your mind at all.
It is, actually. It's funny you say that. We were just actually speaking about this week with a number of my colleagues.
I think it is challenging. I mean, there was a large, well-known top sort of shelf research university that I saw one of their, one of their, like, magazines that they published, and there was, and they were, like, advertising kind of how great they were.
the front of it was like, you know, two unitary robots. And I was like, come on, guys. Like,
honestly, like, we can do better as a country. You know, we have been the home for boss dynamics
for, you know, over two decades. And I think to me, this is an opportunity where we should think
about it in terms of the larger AI stack. And if you start building from chips all the way up,
you know, the ultimate manifestation of all this is where a lot of these ultimately robots play
out. It's this marrying of the physical infrastructure with the digital.
itself. And I think we need to do a lot more as a country to be able to propel that industry
forward, to make it economical for the adoption to happen. And it goes back to something I talked
about a little earlier. It's a lot about trust. You know, and I think there's, you know,
if you think about kind of the dynamics, oftentimes in the global marketplace, funny enough,
the Europeans tend to be a lot more, a lot more quickly, quick adopters, or early adopters,
a lot of this technology, just because of the issues that that they have with some of their
some of their workforce. So I think for us, we want to create an environment where we can build these
robots into our economic growth plans here in the U.S. and think very critically about the way that,
you know, we want safe, secure, and trusted technology used by Americans in America. And if we
see, you know, foreign companies that are not, you know, safe, trusted, and secure and are compromised,
there's lots of tools that we have in our arsenal to protect our ecosystem from it. And the U.S.
government for example banned DJI for use by by the federal government and there's lots of other
examples like that yeah okay actually last question lot is tough of mind do you fish what's the biggest
fish you've ever caught we'd like to ask that to everyone that joins the show oh man I thought that
was coming I actually do not fish so if you guys ever want to take me fishing we'll have to go
sometime I don't I haven't either so we can we can go together and and figure it out on the fly
yeah well thank you so much for taking the time to come talk to us in your busy day
congratulations on the Genesis mission we're very very
excited for this. And have a great
Thanksgiving. Happy Thanksgiving.
Happy Thanksgiving. You guys too. Let's do this again
soon. See you. Goodbye. Cheers.
Let me tell you about profound. Get your brand
mentioned in chat. GPT. Reach millions of consumers
who use AI to discover new products
and brands. Let me also tell you about
TurboPuffer, service vector, and
full-text search, build from first principles
and object storage. Fast, 10x
cheaper and extremely scalable.
Founder mode is right. We have Sebastian
from Klarna in the Restream waiting room.
We're going to bring him in to the TVP
Ultram.
How are you doing?
Great to see you again.
It's been too long.
The last time we hung out, it was just another, it was just another day at work for you.
You just stopped by.
Nice.
You did your IPO and you jetted back home.
But it's great to, it's great to be back.
Yeah.
Kick us off with a review.
What's it been like being a public company CEO for a couple months now?
Well, we said to ourselves on the management team, like, we're never going to watch the
stock price.
Never, ever.
And then every day it was like, what?
Why didn't go up?
What?
Get them.
And then somebody like came to us, guys, just like put yourself next to all the other stock.
And like, oh, yeah, it's moving the same way.
Got it.
Okay.
Got it.
Got, got, got, got.
It wasn't just us.
Yeah.
So.
Makes sense.
Well, big news on Tuesday today.
Please break it down for us.
What's the news?
No, I think it's, you know, I think I was, it's kind of funny because I, like, about a year ago, I was like giving crypto a second chance.
I was always like, you know, I was a little bit.
bit of the, on the skeptic side over the years, and partially it's because, like, my lackmust
test is like, how is this going to help my mom, right? And as much as like, I'm getting excited
about like financial revolution, you know, kill the central banks or whatever. Sorry, I shouldn't
have said that. I'm going to re-quote. You know, bring financial liberty to the world. That's the way.
And those things. The point is that like, that doesn't get my mom much excited. She's like,
what? Can I just pay cheaper or can this be faster? Like, she doesn't really care that much about
The noise in the industry was insane.
I mean, it was so many just regulatory arbitrage moments, so much just like fraud and grift
and also just like pumps and dumps and all sorts of just like memes and things that weren't outright frauds but had just like total.
But the potential was always there.
There was always a little bit.
And the technology was always a little bit real.
And I'm sure I imagine like what like I'd love to understand how you how you're thinking evolved on stable coins.
time.
Yeah.
Because back in 2021, what happened was some close friends of mine called Sequoia said like,
Sebastian, you really have to take a second look at this.
And I was like, okay, fine.
I'll do it.
And they introduced me to some amazing founders among them, a bridge that we now partner
with.
And so I gave it a second chance.
And I listened to the stories.
And I realized, yeah, okay, so I've been wrong.
Technology has now moved ahead.
it's now fast, it's now efficient, it actually solves real problems.
And so we, and then I wrote that on X and I was like, nobody's going to care because we're like,
we're the last fintech in the world.
It's not going to make any news. But it was surprising, like over a million people views on that post.
And since then we've just working hard and like, how do we integrate this into our stack and
what can we do? And today we announced that we're doing the Klona stable coin,
which is one of many things which we're doing with,
bridge and tempo, which is, you know, together with Stripe and the team over there. So,
so that's really exciting. But obviously, you know, there's more to come. It's just that like
we're, we're testing the waters and trying, trying out what will work for us. So, yeah,
walk me through what the first few implementation points look like. If I'm going and I'm paying
and I'm on a checkout page, right now I can check out with Klarna. At what point do I actually
interact with Klarna coin, the stable coin, when does it actually come into the workflow?
So so far the start of this actually is just that like we obviously want to bring these
services to the benefit of our consumers and in their day to day, you know, using a clana.
I mean, we have a big neobank ambition, right? And we have over 100 million users worldwide,
but most of them will only use us for a single transaction. Thank you. Sometimes it's
It's like, you know, a lot of those by now or later, but actually over 20% of them are debit,
where people pay the full amount as well.
So it's a mix.
And now we're trying, you know, we're trying to offer ourselves more advanced services, more
neo-bank services, right?
So we have our card.
It's pretty cool.
Like, you know, we are now 3 million active card holders a quarter ago.
We had zero in the U.S.
So exactly.
I'm going to drop a lot of numbers.
I'm going to get a lot of beeps.
So that was like, yeah.
So that's been great.
But obviously we want to add peer-to-peer.
We want to add the ability to send money and so forth.
And then we've been looking at different solutions.
But what's interesting, I think, here is that even though that's the natural next step of, you know, offering using stable coin for that because it's a very efficient way to send money fast and at low cost.
We also actually realized that, look, I mean, we're processing over $100 billion worth of volume every year.
and we move ourselves quite large money between the US and Europe and so forth.
And this may actually be very efficient even for our Treasury Department to use as a way to
move money.
So we've seen that there's a tremendous number of use cases, maybe more than we realized
when we started looking into it.
That's exciting.
And that can drive, you know, anything that obviously drives our efficiency will also allow us
to offer services at lower cost and more value to our customers.
Can you break down specifically what's happening at each kind of level of the
stack. So you have bridge, which is, from my understanding, the infrastructure that you're using
to actually issue the token. Then you have tempo, which is the blockchain in which you'll be
moving it around on. Is that? And then you have obviously the product layer, which is the
interface that consumers will use to move around. Is it USDK? What is the ticker? I think it's used
I think you've described it pretty well.
I was like, thank you.
That's a good summary.
I'm not trying to understand.
And then you also have, there's a corporate treasury use case where you could,
you're saying you could use the same, uh, token internally as well.
Yeah.
I mean, yes, exactly.
I think also then people discuss a bit on the merchant side, but,
but the truth is that we mostly today, uh,
distributed through Stripe and Adjian and the big PSP.
So mostly the kind of merchant relationship happens directly with them.
So to us is mostly,
what we can do on the consumer side.
But I think there's more opportunities.
I mean, this is just like, again, people are like,
oh, why did you do it this way and not that way?
Why didn't you use Solano, Ethereum?
And why didn't you, you know, whatever.
And what about Bitcoin and so forth?
And to me, it's like, yeah, but come on,
this was just like one first thing that we now announced.
And obviously we are working on more things
and we want to utilize these technologies to more use cases.
And we have more things, but we are not yet yet to announce them and talk about them.
So more to come.
Fantastic.
Last question from my side.
Who do you think is, or what, you don't need to say a name of a company, but like, what type of, what type of player in the financial industry loses out most if stable coins really take off?
It feels like at a certain point, we're just shifting take rates around.
there's a lot of different transfer services that could benefit a lot from higher speeds and lower fees.
It seems like consumers could benefit a lot.
But do traditional payment rails suffer?
Do government suffer?
Like, what category really needs to be on their back foot right now?
To me, it's really, and I actually talked about this a little bit on our earnings goals as well,
is that I actually think, like, to me, I put the whole crypto thing in this wider AI change that's about to happen, right?
And if you look about it, both Finn and tech have been extremely inefficient market,
which is why you've seen the excesses in profits and excesses in, you know, as I quoted there,
like, you know, the gourmet cafeterias used to be called culture and now they're going to be called overhead.
The point is that like there's been this huge excess because it hasn't really been that strong competition.
And why has there been lack of competition goes back to kind of classical microeconomical theory,
which states that if it's hard to compare,
to products, if it's, if, you know, too many legal terms that are hard to understand and so forth,
then people will be fooled and will take products that are less good for them, right?
And AI and new technologies brings a fantastic amount of transparency.
You can just ask, compare these insurances, compare these banking products, what is the best
one?
Compare these credit products, which one is actually the best one for me, right?
So that's going to change.
The second thing is the major one, which is very connected to crypto, is switching costs.
So the big reason banking is,
more competitive is simply because with such a hassle to move.
You know, like I want to bring all my stuff from this bank to that bank.
Yeah.
And people just don't have that energy, right?
Like, people don't have that energy and all the accounts and the salary coming in and all that stuff, right?
So what happening is with technologies like crypto, with AI and the combination of that,
what you're going to see is going to see switching costs coming down to almost zero, right?
It's just going to be much easier to move between different services.
And it's just going to put this massive competitive pressure.
on this industry. I mean, financial services make over $500 billion in profit. That's the profit pool
that we're after. And then tech in advertising and tech is another $500 billion. That's a trillion
in profit pool. And so what I think is going to happen is you're just like, if you are willing
to be customer-obsessed, efficient, you know, and with efficiency, operational efficiency,
crypto plays a role because it can help you be much more efficient. You can be
move faster at lower cost and so forth, then the players who take the advantage of these technologies
are going to make a massive dent. And the benefit, I believe, and you can call me naive
or you can call me, you know, optimist. But like, I believe that the value of this is all these
excess profits that we see in banking, they're going to come back to consumers. They're just going to
make consumers are going to pay less for higher quality services. And some financial institutions
will lean in and they will transform themselves and they will be more customer obsessed.
There will be less marble offices, less beautiful, you know, buildings and all that stuff.
And there will be more of just like waking up every morning, just like a restaurant or any other business for the sake, where you actually wake up every morning.
You're like, how do I bring my customers in?
How do I make them happy?
And how do I run my business so I'm operationally efficient, right?
And that's a huge difference.
And I think crypto plays a role in that.
So I think that's what's coming for Finn and tech.
And if you're willing to be that customer obsessed and run those operational efficiencies and be smart and use these technologies.
There's obviously tons of opportunity of growth and you can build trust with your customer base.
But if you're going to sit there and still continue making the kind of prophecy you are today and think that nothing's going to change, well, eventually you'll wake up, right?
Just like, you know, whatever, airlines did when low-cost airlines came in.
You know, we've seen this over and over again.
They're like carriers when the low-cost carrier things came in.
Like, it's happened before, right?
Yep.
Well, thank you so much for taking the time to come chat with us.
We will talk to you soon.
Have a great rest of your day.
Great to get the update.
Thank you.
Good to see you.
Talk soon.
Cheers.
Before we bring in our next guest, let me tell you about public.com investing for those who take it seriously.
They got multi-asset investing.
And they're trusted by millions.
I'm also going to tell you about numeral.com.
Let numeral worry about sales tax and VAT compliance.
Compliance handled so you can focus on growth.
We have David from one password in the Restream waiting room.
Now he's in the TBPN.
He's back.
Welcome to the stream.
Welcome back.
We have a big update for you.
since you came on the show last time,
we onboarded the whole team onto one password.
John, we were using it individually.
There were some passwords being stored in the notes app.
We corrected that.
Yes, yes, yes.
I'm glad I was able to shame you into action there.
Yeah, yeah, this is real like customer development,
getting your hands dirty, rolling up your sleeves.
You go on the podcast with 10 employees and you physically tell them,
download my app.
And it worked, it worked.
You can't.
One customer at a time.
Thank you again for your trust, both with your business and your personal life.
Yeah, we're very happy.
It's been a huge upgrade, and I think it's going to sail to being a valued piece of
infrastructure in this organization for many years.
But we're also very excited that you've been on a tear.
Your business is doing better than ever.
Give us a little update.
What's new in your world?
Yeah, so we have a little announcement just to refresh some of the statistics of the business.
a couple weeks ago.
So we are over $400 million of ARR.
Whoa.
There you go.
Love it.
A spinning hit.
Spitting head for 400.
We've done that.
We've grown to that level profitably all the way from inception, which is really cool,
you know, durable growth profile.
And we continue to be very profitable.
We now, we're known as a consumer app for a long time,
but now nearly 80% of our business is selling to business customers.
Yeah.
180,000 business customers use the product.
180,000 and 1st,000 and 1,000 and one guys, so thank you for that.
And, you know, we support over 1.3 billion credentials that are managed in our system.
And we have, you know, over a million developers using the product.
So, you know, we feel really good about the trajectory that we've been on.
We've also, in that announcement, we also announced that we've added to the team.
So we've got new leaders driving ecosystem and the revenue side of the business,
enhance the tech side as well.
We're really just setting ourselves up for the next chapter here.
And, you know, as we chatted last time when we were together, we just see the opportunity around AI is really something significant for us.
And we're going all in.
Yeah, I want to talk about that because it feels like there's, is there a fight coming?
Because credential management on the developer tool chain side, the API keys, that's traditionally been a completely separate industry, a completely separate, you know, I don't even know if you guys run into each other at industry conferences.
It feels like a very different world.
One's a developer tool.
One's a consumer tool that you use with your family.
Then maybe you wind up using it at work.
There's single sign-on.
There's all sorts of different ways to manage credentials.
How much are they blurring?
How quickly is this happening?
How are you thinking about setting yourself up for the world where?
I mean, Shulto from Anthropic was on the show yesterday saying,
we're creating a co-worker.
Digital co-worker.
Sounds like a digital co-worker.
He needs some passwords every once in a while.
How are they going to get it?
Absolutely. I think the traditional identity systems that have been siloed and sort of different parts of the puzzle and really hardwired into big enterprises over the years. They don't really know. They're not set up to support this federated dynamic environment where applications spring up and agents need access that are very, very specifically scoped to what they're trying to accomplish. And then they need to be sort of tracked and managed and many times revoked. And so that system of identity and access management really doesn't exist. And we're in really good position to support that. And we're doing a bunch of.
of things already to help people use AI tools securely. I'll give you a couple examples.
So we were a launch partner with perplexities, comet browser. I'm not sure if you've seen that.
But then shortly thereafter, OpenAI and Chatchup T Atlas came out. And immediately, both
they and we got besieged by a customer saying, I need to be able to use one password with
Atlas. I can use this thing and listen it. So we got on the phone with them and we started working
together with them. And quickly, we made one password available as a browser extension on Atlas
with a little bit of a workaround.
And then just today,
we announced the release
of a fully optimized,
you know,
onboarding experience,
optimized for the workflow experience
and the Atlas browser as well.
And so what we learned is like,
look,
customers,
they want to use these tools,
but they want to be able to use them
safely and securely,
and they want to be able to have trust.
So that's what we've always been about
is bringing that trust to the table.
And so we'll be wherever our customers need to be.
Last time we were talking about the headless browsers
around a browser base,
but like with perplexity and Atlas,
this, you know, our customers want to be able to use these tools without having to give their
credentials over in raw form.
So that's one aspect of it.
The other is what's really interesting is, you know, we're moving from applications being
developed by software engineers to being developed by everybody.
And it's amazing how much of the agentic applications that are being created are not
necessarily by software developers.
And so it's great.
It's very powerful.
The whole organization can figure out ways to leverage it.
But again, if you need API keys to be part of the, you know,
you know, in the environment that you're building, or SSH keys, you need to be able to actually
have those things secured. And so our developer tools, they sync with AWS secrets manager
at runtime. They allow you to put a pointer to environment file that tools that we build so that
your credentials are always encrypted, end-to-end, fully traceable, fully revocable.
And so that's the beginning of what you'll see. And then, you know, where we're going from here,
you know, discovery of agents, governance around it. How does it?
interact with the observability systems.
There's a whole green field of things there that we're really well positioned to participate in
and really help define the standards.
So, you know, we're going for it.
It's a very exciting time.
How are you thinking about resiliency?
Do you have any tips for folks building, you know, mission critical systems these days?
It feels like we were fighting an outage with AWS at one point.
Cloudflare went down.
We don't have nearly the resources that you do, I'm sure.
But what tips and strategies have you used?
because I feel like you're definitely going to hear if one password goes down.
Yeah, you know, look, we, we are a cloud-fair customer, right?
So we, we, we, how our marketing site was down.
Our service wasn't down.
Sure.
So, you know, we are using, you know, obviously do redundancy and, and fell over procedures.
And we've got, you know, we come from a security-centric approach.
That's probably what's differentiated us from a lot of the other players in the space.
like security is job one and job 10 and like nothing else matters until we're sure that
everything we're doing is the utmost security.
So we've got a lot of resilience built into the way we do it.
But I think just generally people need to be aware.
Like the threat profile is so much more hostile than it's ever been and it's going to get
a lot worse.
I'm sure you did a bunch of work on the disclosure that Anthropic put out around that.
And it's not just, I mean, anthropic, you know, as you know,
they have like nation state level security, you know, enforcement.
They have like bunkers and all kinds of stuff that they've got to worry about, right?
Because they're, you know, hugely a big target.
But it's not just the biggest guys anymore.
It's really, anybody can be a target because you can do really sophisticated social engineering at scale
with almost no effort at this point.
And it's going to get worse and worse and worse.
So the number one thing that people, you know, will expose is weak credentials.
It's another really good spot for us.
like credential, credential hygiene is more important than ever.
So whether it's you're using Atlas and you're a one password customer, great,
make sure it's connected.
If you're not a one password customer, you should go get it if you want to use Atlas, right?
And if you're a developer and you're building an application and you're not and
you're hard coding credentials or SSH keys, et cetera, into the files, don't do it.
Get a one password license, super easy to use, keeps you secure, keep everything ever locked up.
And, you know, maybe we'll get another new customer out of this.
I love it.
What's your timeline to a point in time where the average American on, let's say, a weekly
basis will be sending an agent out to do something for them and the agent needing to actually
utilize the, you know, like actual login infrastructure of the user. I'm talking about that,
imagining the workflow where my agent's doing something and I get maybe a one-password
push notification that's, or I don't know exactly how the workflow would work.
but saying, hey, I want to do this.
Do you approve it or not?
And then I hit, like, yes, like basically authorize the agent.
So that's exactly what's happening with browser base, for example, right?
And the headless browsers that we're doing exactly.
It's low friction, user verification so that allows you to keep things secured.
Look, we're seeing tremendous uptake on the, you know, Atlas was a really, was enlightening
to see how many people are actually trying to sort of utilize the browser and have it do things on its behalf.
certainly the other partnerships we've had.
We're so early days on it.
But I think when we're going to hit this inflection point where people realize,
I mean, I'm starting to see how valuable in both my professional and personal life the tools can be
and just shortening my day.
And obviously, I want to make sure I'm doing it securely.
I think most people are going to be in that mode before we know it.
And so we just want to make sure we're available for our customers when those moments come
so that they can do so securely.
Last question.
What's the biggest fish you've ever caught?
Well, I'm more of a fly.
I enjoy fly fishing more than I do like deep sea fishing.
You know, getting sick on a big boat and falling in a big mowling.
Yeah, deep sea fishing is the ultimate hack if you just want to catch the biggest fish, right?
It's not, but it's not a pretty simple.
Somebody else catches it.
Yeah, I really do.
Yeah, my son, my son prefers fly fishing, so I follow him.
He likes to catch a big bass.
Then where is the best fly fishing spot?
You know, I like Montana and Utah.
Utah. Utah. You like Utah. Utah and Montana. Utah, Fisher will smaller, Montana a little bit bigger, but, you know, two really good spots. And, you know, just, you know, give a show. We're going to become, we're not, we're never going to leave this building, but we're going to become fishing experts. We're never actually going to know.
Just through our guest. But just through asking every guest a little bit more of actually. Eventually, this will just be a fishing show. I like it. I like it. Get yourself a guide. Go on a fly fishing trip. Take a weekend. Go to Montana. You'll love it.
Thank you so much for coming on the show.
All right. Happy Thanksgiving. David. We'll talk to see.
Let me tell you about Vanta, automate compliance and security. Vanta is the leading AI trust management platform.
One thing that's cool, back in 2019, one password raised from Excel. And when they announced it, they said Excel will be investing 200 million for minority stake in one password. And you don't see that positioning a lot. But, I mean, it was a very minority stake. Obviously, they put in.
They put in about 200, I think, at, was it 200 on one or two billion?
But anyways, absolute beast of a business.
Well, up next we have Keller from Zipline.
We're very excited to talk to him.
There's some big news.
The eagle himself.
Yeah, I get that ready.
First, I'm going to tell you about Figma.
Think bigger, build faster.
Figma helps design and development teams build great products together.
And there's someone who built a great product.
with lots of talented individuals.
Keller from Zipline will bring him in as soon as he's ready.
Oh, I don't think he's ready yet.
But we can go over to the timeline.
Yeah, we have a post here.
Uh, somehow, no, I'm going to jump.
Oh, where are you going?
Okay.
Somehow, uh, David Yulovich, former guest of the show, said,
turns out huge swaths of the BS on this platform that claims to be from the U.S.
is all foreign.
And then this, uh, somebody, he'll quoted.
And somehow the A16Z account is based in Canada.
I really don't know how this is actually possible.
I want to see if it's been updated.
I did check all of her accounts, and I think we've been marked safe.
I haven't checked actually most of the team, Tyler.
I don't know, maybe just secretly.
I just know so many.
I have so many friends at Andrescent.
I don't know how.
I don't know.
None of them are Canadian.
Why does Tyler's accounts say it's based in North Korea?
I don't understand that.
I know.
Have you been to Pyongyang recently?
Is that where you're going over the holidays?
Yeah, you said you're leaving.
This is miss info.
He goes, oh, I have a dentist appointment.
I can't come in tomorrow.
He can't come in.
He's going back to Jiang Yang.
For a little touch base.
Yes, yes.
What happened with this meta-wistleblower situation?
Adam Dell says I'd love to see TVP.
Well, you're not going to see it.
You're not going to see it discussed right now.
I do want to discuss it.
But we have our guest here, so we will bring in Keller from Zipline.
Welcome to the show.
From the floor.
Fantastic set up.
How are you doing?
Best comms team in the game.
Good to see you.
How are you guys?
We're fantastic.
You look great.
Give us some updates.
Give us what is the latest news in your world?
Very excited for everything that we've been seeing on the timeline.
I want to go into all the jokes about what happens if you shoot one of these down.
But first, let's get the serious update.
Let's get the serious questions out of the way.
I mean, yeah, there's a ton going on.
The thing we announced today is that Zipline just signed a $150 million contract with the U.S.
State Department.
Yeah.
You know, to triple the size of our life-saving autonomous delivery network across Africa,
we're going to go from serving about 5,000 hospitals and health facilities to over 15,000.
We'll add about 130 million people to the network who don't have access today.
And the last cool thing about that is that that 150,000.
million comes with up to $400 million of co-financing commitments from the African governments
themselves.
Okay.
So, you know, this is not, this is not- Just straight on the taxpayer.
Yep.
Yeah, exactly.
Yeah, yeah, yeah, yeah.
This is actually, like, encouraging investment in this kind of infrastructure.
Yeah, so was this delayed because of the USAID pullback?
There's been a lot of, like, back and forth on how much the U.S. would be investing internationally,
what would be happening?
Has the dust kind of settled there, and there's now time to actually go do a partnership like
you just did? What's this kind of state of the union? Yeah. I mean, you know, obviously earlier this
year, that was like the first phase of a big shift in terms of how the U.S. is interacting with
developing economies. I think this new vision that's now being talked about by the State
Department of commercial diplomacy. The whole idea is let's not, you know, let's not treat these
countries as charity cases. Let's actually treat them as allies and trade partners. And the good news is
these countries have been saying for a decade that they want trade, not aid.
They're sick of low quality services provided for free by NGOs.
What they want instead is high-paying jobs, entrepreneurship, technology.
And the thing is, like, that's what the U.S. has to offer.
You know, like, we can deploy AI and robotics infrastructure into these countries
in a way that will save lives and kind of turbocharge their economies.
So, 150 million from the U.S. State Department,
matched with 400 million from the partners internationally,
10,000 health facilities.
How many actual drones is that?
How are you actually thinking about scaling your, like, what does this allow you to do?
Are you going to be staffing up, hiring tons of people?
Is it just build another factory?
Is it a dedicated factory?
Like, walk me through how you plan to actually use this money over the, however long,
you're planning to work on this particular growth initiative.
Yeah, I mean, look, in a way, this is coming at the worst possible time.
Because, as you guys know, the U.S. business is growing.
really fast.
We're in the middle of, I'm here.
Yeah, I'm here on the manufacturing floor.
I mean, you can see like dock electronics
happening over here, Zip Platform 2, Zip Manufacturing.
And then if we were to go straight behind the camera right now,
we're just opening up a new 100,000 square feet
of manufacturing facility that will produce both
the Platform 2 technology as well as accelerate
manufacturing for this specific contract.
The, you know, we're, we're,
in total, this manufacturing facility is capable of building about 20,000 autonomous aircraft a year,
and it's all happening in South San Francisco.
So this is kind of, this is the cool part of this compact,
which is that, you know, this is not just a big deal for all these African countries
that are now leading the world in terms of deploying autonomous infrastructure to save lives.
It's also really good for the U.S. because we are sort of securing U.S. technology
and manufacturing leadership for the decade to come.
This is creating high-paying jobs in the U.S.
And it's accelerating all of our manufacturing efforts here.
Okay.
Let's shift to what's actually going on here.
You know, we've seen the initial partnerships that have rolled out.
What have you learned most recently about, or what has surprised you about the actual application of the technology, the adoption?
Like, where are the underrated use cases beyond the meme that I'm sure will follow you forever,
which is the private jet for your burrito.
So get ready for that one to be around forever.
I mean, we just had Sebastian from Klarna on and his entire business,
which serves all sorts of different customer bases,
has collapsed to buy now, pay later for your burrito because they did a partnership with
Tramor.
Burritos are powerful.
I think it's actually a bullish indicator if your business is getting burrito memed.
It is, it is.
But yes, where do you see the shape of the U.S. business going,
where are the exciting developments these days?
I mean, look, you know, on, you know, Saturday, Zipline hit an all-time new record number of deliveries across the U.S.
Then on Sunday we blew that record out of the water by 10 or 15 percent.
So, you know, it's like every day is basically a new record at this point as a company.
I would say the most interesting things are it feels as though we accidentally like stuck a pipe into the Pacific Ocean.
Like demand is so vastly outstripping our ability to build capacity for this kind of service.
And keep in mind, I mean, right now, you know, we deliver products in two to three minutes.
So even from like when a customer presses a button to have something delivered to their front yard or backyard or front doorstep is typically around 15, 16 minutes.
And so it is very magically fast.
That results in customers changing their ordering behavior.
Like, you know, a lot of our customers say they'll grocery shop once a week and then they'll order from Zipline three to four times a week.
So people are using Zipline more than the average Amazon Prime subscriber uses Amazon Prime.
And not only that, but one of the big changes just since, you know, I was last on with you guys, is that a lot of these restaurants are really accelerating.
We're now doing 15 to 25 percent of deliveries from these restaurants that we've integrated with.
So we are a similar size on a per delivery basis to the.
the big delivery platforms.
I think, you know, maybe the people still think, oh, the technology is like sci-fi.
It's like years away.
And it's funny sitting here thinking like, wow, I mean, this is like completely normal in the
neighborhoods that we are, that we're serving.
Talk about the actual experience of getting, let's say, items from a restaurant.
We had David Chang on.
He was excited about drone delivery and the technology.
I tweeted at you guys.
Yeah.
We're going to try to get it.
We're going to try to deliver for him in Dallas.
Yeah, yeah.
And specifically he was saying he didn't think it would solve the delivering something hot from my point of view.
If I'm used to getting something in 20, 25 minutes and then you deliver it in three minutes,
like that feels like it will be a material improvement.
So I didn't quite understand what his point was.
But what's the actual experience been like for people?
And what's kind of the average speed up in terms of delivery times that you're seeing?
I didn't really understand what David was saying either. But look, like, the, you know,
our comms team hates when I talk about this. But, you know, like, one of the first food deliveries
we did, the customer badly burned their tongue on the food. Okay. Yeah, I can see why they don't like this.
And I heard that. That's the restaurant's fault. They served food at a dangerous. Yeah, yeah, yeah. It's kind of a
bad thing. I was like, you know, actually, we should make this like a core part of the marketing.
Like, that is crazy that customers are so not used. They're so used to getting like fried.
They're 45 minutes old and like ice cold and soggy and gross and food that taste bad and milkshakes that are
melted and we just put up with this shit, man.
Like we're completely used to it.
And so, you know, I really think this is going to, you know, in the same way that maybe David's
expectations are going to get kind of reversed.
Like it's totally happening with all the customers.
When you can get something delivered and there's only, you know, two or three minutes from
when the thing comes out of the oven, when it is delivered to your front doorstep, that is a way,
different customer experience. I think actually people are underestimating the difference in the
quality of that experience. Like food tastes really good. It's almost like you're having an in-restraint
experience at home. I wonder, so I remember when the delivery, when the delivery boom happened,
and all of a sudden people were ordering way more food. And it was really like a Tam Expander.
There were obviously ways to get delivery. You could order a pizza 30 years ago on the phone. They
would deliver it. But when it became an app and the market expanded so dramatically and people
were starting to, you know, DoorDash and Uber eats like every night, lots of people did this,
the market grew and it actually changed the nature of our food. And we got ghost kitchens.
We got these funny knockoffs like there's in L.A. There's sugarfish. And then I saw one that
was like sweet. It's like they will deliberately try and change the names as close as possible.
And you get these like kind of restaurants that only exist because of the new technology.
And I'm wondering what you think of the.
impact, if there will be a change in the nature of the food or the nature of the restaurants
just because the delivery time goes down or because of the shape of the box.
Like if you can't do a massive, you know, six foot pizza, maybe, you know, some smaller
products like emerge is like the dominant form factor and the restaurants that conform first.
Six foot pizza, John?
I don't know.
Size of this table.
I don't know.
Yeah, I, I, you know, the kids' birthdays, you see those?
Yeah, yeah, they're pretty big.
It's not six feet.
It's not six feet.
But you get my point.
You know, will there be restaurants that are like, okay, we're going all in on Zipline?
We're thinking about developing meals from first principles that fit for the best possible experience on the Zipline platform.
And then that becomes like a new thing that actually changes our culinary experience.
I mean, I, you know, I'm not an expert, but I have a bunch of like hypotheses.
and I mean, I would say a couple things.
Like, first of all, I actually think we have to do a ton of design of the food now
to make it work for a system that, like, is going to deliver the food 45 minutes later
and ice cold, you know?
And also, there's a lot of innovation that has to go into the packaging,
because I don't know if you're familiar, but like 60% of food delivery drivers report
eating some of the food that they delivered in the last 30 days.
Oh, no.
So we're like doing all the temporary packaging.
60% over, like, hopefully over the food.
the month. Not 60% of every time. Or the last month. Not 60% every time.
Okay. Okay. Okay.
Over a month. They're like, but only when it's really good.
Don't tell me.
Only when it's really good. Only when it's like my top five favorite restaurants.
One fry. One piece of sushi. Sorry if I'm, sorry if I'm ruining it for anybody.
But like, you know, so we have to innovate on like tamper-proof packaging.
We have to figure out like safety and we have to figure out reliability. And like, you know,
some percentage of things just get picked up and then never delivered. And a lot of things,
actually like the driver will accept the order, but then actually just never show
at the restaurant, then they have to throw out the food, remake it again. So, you know, I think there's a
ton of inefficiency and cost in the system that we will just don't think about, but you do end up
paying for in fees and, you know, all the crazy fees that get added on top plus tip.
I think another big thing that's going to change is that, you know, this technology is designed
to be able to fly out to 10 mile, 10 mile radius. And typically it's not cost effective to deliver
something with a car more than like three or four miles. And so that means, you know, it differs
on by Metro and where we're talking about. But like that means that these kinds of systems for any
given restaurant, you're going to enable about 10 times as many customers to receive instant
delivery from that location. That's a big deal. And it's a bigger deal actually for like mom and
pop restaurants or kind of local heroes versus a really big chain like Chipotle that actually has a ton
of stores. And so I think, you know, especially when you think about a place like LA, for example,
where you have a lot of these different parts of the city that are hard to reach. Traffic is terrible.
you know, it can take an hour plus to get delivery of food.
You know, this technology is going to be like transformational.
And you can deliver a lot of like the best, most beloved kind of local hero brands and make it universally accessible.
By the way, on the university accessible front, you know, some of the cities were serving in Dallas right now.
I mean, just one city that I was looking at the statistics for yesterday, 46% of homes are ordering from Zipline in that city.
And so I think people don't appreciate.
Yeah, exactly.
I thought it was like a map error when I looked.
You know, people that talk about startups getting like 2% market share, 5% market share.
It's like, in a few weeks, Zipline will literally have the majority of homes in our service area ordering from the service.
And that is like, that's not a joke.
How are you, so clearly, clearly it's working.
Clearly customers like it.
There's an insane amount of demand.
How are you pushing the team to move faster?
because at the same time, yeah, I know you want to, you know, be practical about the rollout
and not get over your skis, but at the same time, I mean, people in our chat are,
anybody that sort of knows that exists, they start to become angry that they don't have it in their area,
and I'm sure there's people sending you messages all day long asking you,
when are you going to be here, when are you going to be here?
So, yeah, we don't, we're going to be announcing something very,
shortly. We just started talking about it internally, but we'll be announcing the next two
metros that we're launching in Q1 and Q2. So look for that in the next week or two. You know,
we're then going to start accelerating and adding multiple metros a quarter starting in the
second half of next year. So we are trying to move super, super fast. You know, hardware companies
are hard in that, you know, you have to scale all these different parts of the business
simultaneously. It's in the name. And also it's like, you know, you got to
to make really sure that you don't accidentally bankrupt the company. And actually, the faster
you're growing, the easier it is to bankrupt the company. Because like, you know, these numbers,
when you're building 20,000 autonomous aircraft a year, the numbers actually start to get really big.
You got to make sure that, like, the hardware is validated. And, like, you have, you know,
sites that these, that the hardware can go to and begin operating, you got to make sure that
aircraft utilization is high. If you make, you know, there's, there's a lot that has to move in
tandem in order for the business to work. So, I mean, to put it into perspective, right?
Right now, flight volumes have been growing about 15% week over week for the last 30 weeks straight.
We are now planning for next year.
Yeah.
We're planning for next year and we actually just reforecasted the entire business and we are planning to actually double our growth rate next year relative to what we were planning just at the beginning of this quarter.
It's, yeah.
And I don't know how much I can, you know, we are definitely anticipating like exponential growth over the coming couple of years.
to do a whole DCF at this point. It's fantastic. Thank you. Just send it straight to Wall Street.
I appreciate it. This is so exciting. Congratulations again. It's always a great time.
You guys got to come to Dallas, I think.
Yeah.
I think it's probably at a point now, you know, when I was in Dallas last week, like,
we were just hanging out at all these different, you know, these different neighborhoods
that are using Zipline.
And there were neighborhoods where I saw more zips than I saw cars.
Wow.
And so I don't, you know, it's funny how the, you know, the futures here is just not
evenly distributed.
I think there are, you know, certain parts of the U.S.
People are like, oh, yeah, it's sci-fi.
Like, you know, it's totally goofy.
And then there's like, yeah, some metros are people like, oh, yeah, I use it like three
to four times a day.
And by the way, these are like predominantly, moms and grandmas.
There's a lot of AI researchers that say that getting Waymo into DC will significantly update the administration's AGI timelines because they will just see robots on the street and they will recognize that this is a real thing.
And until you actually see it diffused in the world, it's very hard.
It's very abstract to just see reports.
Oh, Waymo has a thousand rides or 10,000 rides or a million rides.
It's like, what does that mean?
But when you are walking and it's like, oh, seven waymoes in a row, and they're all driving fine, not crashing into each other, you get it.
Even Tesla FSD.
I mean, I was hanging out with my college professor and he had no idea what FSD was or that it was working.
We've heard about it for so long, but it's finally here.
So, yeah, very exciting.
Well, thank you so much for coming on the show.
I hope you have a great Thanksgiving.
And we'll talk to you soon.
I'm sure you'll be back soon.
Yeah, you'll be busy delivering turkeys hot.
A whole turkeys soon.
we can do. Small ones you can do. Okay. Great. Great. I love it. Well, congratulations.
Thank you for having me. Great to catch up, Kellogg. Have a good one. Cheers.
Before we bring in our next guest, let me tell you about Julius AI, the AI data analyst that works for you.
Join millions who use Julius to connect their data, ask questions, and get insights in seconds.
And I'm also going to tell you about Privy. Privy makes it easy to build on crypto rails.
Securely spend up wide label wallets, sign transactions, and integrate on-chain infrastructure all through one simple API.
We have our next guest in the Restroom Waiting Room, Royce Branding from Clearspace.
How are you doing, Royce?
Welcome to the show.
Good to have you.
How are you doing?
Thanks for having me.
I'm doing well.
How are you guys doing?
I'm doing well.
Can you kick us off with just a little bit of intro and background on you and the company?
And then there's a whole bunch of questions that I'm sure we're going to get into.
Totally excited to dive in.
My name is Royce Branding.
Co-founder and CEO of ClearSpace.
And we help people reduce their screen time.
our company, our mission is to build the missing intentionality layer of the internet.
We think there's a fundamental asymmetry in the war for your attention,
and we're equipping the individual autonomous consumer in the market
with the ability to steer their focus online and protect their family's attention online.
What's a perfect amount of screen time?
Have you guys run the numbers? Is there an optimal?
Well, you know, Andrew Ross Sorkin asked Peter Thiel this in Sun Valley for his kids.
He was like, you're on the board of Facebook.
How long, how much screen time do you let you say like, he's at 30 minutes a week?
Oh, yeah.
Yeah.
30 minutes a week is ambitious.
I think that the ideal amount of screen time is probably a little bit less than whatever
you're spending right now.
Sure.
We say that a calorie is not a calorie, a minute spent on a screen is not equivalent to
another minute spent on a screen.
Sure.
But you want to be increasing the quality of the consumption.
And usually overall reduction in quantity ends up meeting an increase in quality.
Yeah, that makes a lot of sense.
So how do you actually do it?
I mean, there are screen time functionality
natively baked into Apple.
The iOS, I'm sure Android has it too.
Your business is still working,
so it's not like you're getting steamrolled,
but how do you differentiate?
Yeah, do they have,
is there any sort of misalignment to Apple's business
with screen time?
Because I imagine if they really incentivize people
to use their screen less,
it's like less apps that I'm subscribing to
and less, kind of potentially less, like, they don't have a perfect incentive to make you
use your phone less.
They sell you the phone once, but they're like, take more pictures, get those, get those
iCloud subscriptions up, buy more apps, spend more in that mobile game, et cetera.
100%.
Yeah, yeah, we think Apple has every incentive to have a solution here, but maybe not the ideal
incentives to have an effective solution to helping people kind of control their screen time
and reduce it.
We think that it comes down to both visibility and control.
So you have like a feedback loop that's helping people identify how much time they're spending on devices and like where that's actually going.
I think the current state of screen time right now is basically like again to use food if you only tracked calories that you consumed, not micro and macro nutrients.
So for the last two years coming out of YC, we've been primarily focused on a mobile app that grows people's awareness of how much time they're spending on devices and then allows them to add little bits of cognitive friction into the addictive habit loops that they use on different apps like social media.
And that kind of starts to get them rehabilitating an addictive habit.
But what we're actually working on now, and we just announced a few weeks ago, are screen time agents that sit at your network layer and can observe network traffic going to all your devices.
And this is particularly useful both for individuals and for their families to think about holistically what it means to have the right type of content, the right time of consumption happening across all of their different devices.
And that kind of breaks out of just Apple's ecosystem of what they allow us to see.
Yeah, yeah, that's interesting. How do you think about the responsibilities of different big tech platforms? We were just pulling up this article in CNBC about this whistleblower claiming that meta failed to act to protect teens. Do you have a stance on like, are the big tech platforms being negligent in what they're surfacing to their users? Or do you think it's
more just like the natural forces of, you know, the economic incentives. They're trying to
sell ads. How do you, how have you grappled with the various, like, dustups in the big
tech world over the, like, what happens on these apps? Yeah, yeah. I tend to think about,
no one is the boogeyman. I think actors are kind of following the incentives laid out before
them. Our mission is really much to meet the opposite side demand. I mean, I don't know about you guys.
everyone I know hates their relationship with their phone. They hate how much time they spend on their
device is. And I think what we're seeing is we think that actually equipping them to articulate that
preference in terms of how much they're spending time on these platforms with technology that's
sophisticatedly protecting their attention is going to actually push back against how big of an
intention economy scenario can actually be downstream from people just rampantly consuming content.
Yeah, yeah, that makes sense. So how do I, do, uh, how?
How do you actually, like, take me through a list of like the walls that you run into.
I mean, all the big tech platforms are like famously walled gardens.
Somebody in the chat was asking, like, I would love to be able to use YouTube with no shorts,
only like long form content.
And I actually installed an extension in Safari called Social Focus that allows you to do that.
If you use the browser, but if you're in the app, there's nothing you can do.
It sounds like you're going higher at the network traffic level a little bit.
But at the same time, I don't even know, can you at the router level detect if someone's watching a short versus a long form video on YouTube?
That feels like that would be obfuscated.
Yeah, yeah.
That gets a little harder to do, although we're constantly pressing at the edges of like what is possible around that.
I mean, we've definitely ran some experiments where you can kind of fingerprint what short form content might look like coming down the wire versus long form content.
Yeah.
And so there is like interesting things that you can start doing there.
But really robustly for the mobile app, we can basically just like make sure that you're staying within healthy usage limits and that those aren't sliding out of control.
Which like when shorts go wrong, what really happens is they like pull you into a longer session than you want to be in.
Sure.
So there's not an easy way to do that.
But different platforms have different rules.
Like on obviously Chrome on the MacBook, there's a way higher ability to detect what type of stuff you're watching.
Yeah.
Yeah, yeah, it's, I mean, it's tricky, especially as all the apps like collapse with AI.
You could imagine, I mean, right now, SORA and ChachyPT are separate apps, but in many ways, they're like on the opposite ends of the spectrum.
Like, I want, you know, my, my, you know, son probably spending a bunch of time solving problems in ChachapT and researching things and, like, finding facts and, you know, using it as a helpful assistant to understand the world.
and probably very little time on Sora.
I just, you know, slop it up.
Yeah, what are parents of teenagers actually doing specifically with clear space?
Like, how are they utilizing it?
What are best practices?
Our kids are much younger, five, five and below.
So we've have probably another at least five to seven years before this is even a conversation.
But I'm curious.
Yeah, some of the cool stuff that we've seen,
is people inviting their kids into like challenges as families. So setting up like incentive and
reward systems. One of our most popular. Gambling. Gambling on screen time. The most American thing.
Fight fight one addiction with the other. We, uh, we, we hear a lot of parents like set up family groups
where they're doing a challenge, like a push up to scroll challenge where everyone in the family
or squat to scroll, you have to earn every single minute you're going to spend on social media that
week with a physical exercise that we validate with like a machine learning verified pushup or squat.
And then whoever's in the lead at the end of the week gets to decide where the family's eating
out to dinner on Friday night. I think the most effective solutions we're seeing are kind of
these like cultural pushbacks, almost, you know, community type stuff like the practice of Shabbat
in like the Jewish community where it's like 24 hours everyone's putting their phone away. And
people love it. It's not this like negative you can't use your screens. It's like everyone's kind of
buying into a new fun thing. And
We think ClearSpace is the platform that can empower you to do that, like, really quickly.
You don't have to be a software engineer and know how to hack your router and know how to program all the phones.
You don't have to buy a dumb phone.
You can kind of still participate in the latest and greatest technologies while knowing that they're not completely zapping your entire family.
Yeah.
Totally.
Well, congratulations on the progress.
I know we didn't talk too much about the business, actually, more about the problems that you're solving.
But it's, yeah, it's a very interesting industry.
Thank you.
I'm curious for both of you guys what you're doing about.
your screen time these days?
Most of the time, I mean, I don't know, because all my screen time is actually really low
because I'm live streaming all the time.
And do I count this?
Like, I'm looking at a screen.
I'm looking at you.
The other thing I've always been frustrated with the dedicated.
My screen time is actually way lower than it used to be because I'm live, but that's content
and I am the content.
And so it's a little bit murkier.
The other thing is I was always frustrated with screen time.
I'll give clear space a spin.
But with the core screen time app, it would track like,
call hours as part of the screen time, right?
Which just makes zero sense to me because I'm like oftentimes like not using my screen at all.
I'm just talking with somebody.
And so anyways, I just always, always felt like, I don't know.
I think I've always been more focused on spending time on, you talked about like all calories are not, you know, created equally.
But spending, spending time doing the right things.
But yeah, the best thing I've found is just put.
my phone far away and just staying away from it.
Yeah, last week, I spent eight hours in the Maps app or something, which is like,
I did a commute last.
Map maxing.
It was my number one used app last week.
I don't know what was going on.
I was driving a lot of it.
Putting the phone across the room is what we call a classic low-tech solution to a high-tech
problem.
We think there's an opportunity to basically deploy super intelligence at the network
level at protecting your attention rather than exploiting. And that's like, we think that's what
people want and that's what we're bringing to them. I'm going to really stick it to Apple and just
start breaking my phone into pieces when I want to use it less. And then I got it because I'm on the
whatever. I get the free replacements, right? So then I just go in the next day, get a new phone.
And when I want some less screen time, I just break it into pieces. That's the real low-tech solution.
But excited to give clear space a spin and really glad you guys are working on this.
It's very important that we have the smartest people in the world trying to capture as much attention as possible.
And it's good to have equally smart people working on humanity's side here.
So thank you.
And great to meet you.
Awesome. Great to meet you guys.
Cheers.
Talk to you soon.
Let me tell you about adquick.com.
Out of home advertising made easy and measurable.
Say goodbye to the headaches at out of home advertising.
Plan buy and measure out of home with precision.
Oh, this CNBC story, Meta, failed to act to protect teens.
second whistleblower testified. This is from
2023. So I don't know
why Adam Dell wants us to
discuss this. Is
there something new here? Because
the CNBC story links to
a Wall Street Journal article. And I was
like, oh, November 2nd, it's a little bit old.
But it's November 2nd of 20203.
And so I don't know what
the news is here. Maybe there's
something new. We'll have to dig in.
But we can go and
take a tour of the latest in Meta's
world. The most recent thing that I saw was
that they, um, uh, they beat the FTC case on the, um, on the, on the, on the, on the antitrust
case that they were fighting. So, uh, things to be, seem to be on the up and up. Um,
the latest thing for meta on the, like, is it safe for kids, uh, stuff was from Adam
Masary at Instagram where he was saying he's going to try and make it PG-13. He was using the
MPA rating system. And I believe that there was like some, some pushback from the MPA on whether
or not they could. I was saying, hey, matter, you're rich enough. You should buy the entire
or MPA. I don't even know if you can. It's probably a nonprofit. But like, I want, I want those
ratings like in every app, like just as a consumer. Because everyone understands it. You know
what R-rated means. You know what PG-13 means. You know what PG-13 means. I can even tell the
difference between G and PG now with the kids. Because PG, there might be a little bit of like a
tense moment. It's just like emotionally charged. I used to think PG-G, it's the same stuff, but it's not.
And so quantifying that, using every movie is training data,
pipelining that in, and then filtering every message that gets sent into Instagram, every post,
hey, how would you rate this?
Machine Learning model, AGI God, personal superintelligence.
Let's give every Instagram post a rating and then let the user decide,
hey, I don't want to see anything above PG-13.
I don't want to see anything R-rated.
I don't want to see anything G-rated or PG-rated or anything above that.
If you could set your threshold, I think that would be very useful for parents who want parental guidance on the meta-platforms.
Okay.
We've had a bunch of guests back-to-back.
We've also had some ads back-to-back.
Get Bezell.com.
Shop over 26,500 luxury watches, fully authenticated in-house by Bezels, team of experts.
Okay.
We got to talk about the Kermu, Kian, Exchange.
I thought that Kermew was pretty fair.
Sure.
I think he could have gone harder.
Kian said he didn't watch Kermu's interview,
that he was with a patient.
I wish that he had.
Because it seems like this is one of the most important things
on his plate right now is kind of getting beyond this.
and ultimately we tried to bring up as many of kind of the key concerns as possible.
To be honest, it's technical enough that I don't, that it's, we don't have the same power level
in terms of kind of like pushing Keon on some of these issues.
Yeah, totally.
Cremu and Sichuan.
Which is why I think like a lot of the debates will be done around the data in blog posts by scientists.
But, yeah.
And Keon's main point.
that I took away was, sorry, laughing at the chat, but it was like people are angry that we have
the best marketing and the best science. And I believe that they have the most effective marketing
in terms of capturing attention right now. But I don't have the confidence after that conversation
that the marketing should be happening at the scale that it is. Like, I just don't.
I didn't come away from that super confident that Keon felt like they've done anything, anything at all that's wrong.
Even if you just narrow it to what there is full agreement amongst all participants on,
which is that there were reviews that were anonymized and then not disclosed to be anonymized.
even if it's just that.
Like that is enough to, you know, if you're a customer, be like, oh, like, I don't trust this anymore.
And it's a very, very high trust environment.
It's a very trust critical environment.
It's not, okay, yeah, I'm buying a phone case.
And like, they, AI generated the, like, an example of a person holding up the phone case.
Like, that's not what this is.
This is like life, it's bio.
It's really important.
People are selecting, you know, impact.
Yeah, we've talked about the phone.
child's life.
Yeah, we've talked to this.
And I think that whatever happens...
It's really important to get it right.
It's really important to get it right.
And ultimately, people that use the service,
if they have an adverse experience,
they feel like the service didn't deliver or went wrong.
They're going to come back to this stuff.
So are there any posts that we need to read from the time?
The fundamental problem with Keon's deflection is that even if the origin polygienic weights
can be independently validated to have the predictive accuracy
claimed in their white paper, none of that changes the fact that they
completely plagiarized Harrisite, falsely claimed that origin is novel and has
superior performance, made numerous errors from typos to substantive
mistakes in their white paper, have a history of making literally impossible
accuracy claims, in some cases inflated 2000X to independent replication.
These are not just...
What's up, Tyler?
Oh, I just...
You can continue.
I have another post. I want to talk about it. Okay. Yeah. These are not just restricted to claims about
technical accuracy. These are claims about ethics and morality for the vast majority of businesses.
Maybe you don't really care that that much about unethical practices. Typically, that's fine.
I mean, maybe meta does shady stuff sometimes, but I still use Messenger. Maybe my local grocery
store manager is a wifebeater. Who knows? I still have to buy my groceries somewhere. That's a
oddly specific example. This is the example that we keep giving of like, you know,
You know, will you go change your tires if you find out that the Bridgestone tire company is
buying on, you know, a rival tire company?
There are certain things where it's just like, if the tires are working, like, you're okay
with it.
A lot of it depends on, like, is the criticism directly in line with the company's product?
Like, if the CEO flubs a line and they miss earnings, but the, but the,
But the product still delivers what it is.
It's like they sell apples and the apples taste great.
Like, you're fine.
But when they're making a claim about the actual product and then it doesn't align,
that's where people really, really start to ask questions.
So closing out here, it says,
but we are talking about a company that will select your future child.
How can anyone trust a company where the CEO's first instinct,
when confronted with evidence-based criticism,
is to make false accusation of shady conspiracy theories.
and Kermew follows up and says,
if a company engages in malpractice, e.g. plagiarism, providing products,
they should know our bad two customers, etc.
Is it water under the bridge if they can clean up?
That's obviously a reaction to my question was, you know,
is there a redemption arc in his mind?
Somebody says Volkswagen can answer this question really well.
I think that's because Dieselgate is what's going on with is that in reference to.
Yeah.
Anyway, Kermew also says Kian alleges that he's been working on embryo services for a long time.
Again, that doesn't seem surprising.
I think this was always the longer-term vision of the company.
But Kermew says he hasn't been doing this with genomic prediction, according to their lawsuit,
which says in 2025, nucleus sought to offer IVF products involving embryonic DNA testing.
Because nucleus could not do that work itself, it contracted with GP.
for GP to use its own embryonic genotyping products to provide test results for patients.
Nucleus made overtures about acquiring GP, but soon it became apparent that nucleus was looking
for inroads to misappropriate.
Again, these are just allegations that we can't really validate ourselves.
But again, didn't come away from that kind of more confident in anything, really.
Yeah, the type form, a lot of people are saying that the type form is down.
Kian was, of course, saying that, like, he will release the models and that you can go and get the, the, you can get the, the models and the data from the type form.
It was down at the moment he said that, but Max Glick, uh, thank you for, um, your service doing that reporting in the chat while we were talking about that exact thing.
Max says, it's back up now for what it's worth.
And so Kermew says that's good.
And I certainly hope, I just feel like the next turn of discussion needs to be, okay, we tested the models, we tested the data.
We tested the claims at a lower, at a higher level of rigor, I guess.
Tyler, which post did you want to run to?
Oh, it's at the bottom of the timeline.
Cedgwan Mala is also accusing Kian of using Chad filter.
This has happened before.
This happened before.
So when Keon came on the show, maybe six months ago, growing Daniel accused him of using a Chad filter while on the stream and went super viral.
And I was kind of like, oh, like, that's, I don't know.
I don't know how to even respond to that.
That's a very silly claim.
I have no idea if this is real.
I can't tell at this point
on a Zoom call at this resolution.
What do you think?
Do you think this is real?
Are you guys just cracking up?
Does everyone think it's real?
I don't think it's real.
I don't think he used a filter.
I don't think he used a filter.
I don't think he used a filter either.
I think he's just been mewing maybe.
Maybe he's just photogenic.
Yeah, it is possible that he just, you know,
flexed his jaw muscles and, like, you know,
has low body fat.
I don't know.
I don't know.
I feel like it would be extremely high risk to run a chin augmentation filter.
The filter goes down for a second.
I mean...
Because you know that's what happens, right?
When you're using like the Snapchat filter or like the TikTok filters,
like sometimes they pop in and out.
And if they pop out, like you're done.
Like people are going to be immediately, you know...
Let's see.
Can you hear the first two images with the X.com profile?
I mean, the X.com profile, that picture looks.
three years old, four years old.
I think on this one, Sishron, like,
you might be over your skis. I don't know.
We need to prove it.
And then, yeah, people are really going back and forth.
He's got to get the nucleus test for the gigacad test
and publicize the results.
Everyone's cracking up in the studio.
We're having a wild time.
Anyway.
In other news, this is actually insane.
apparently, according to X, I don't know if this is true,
but the robbery that took place yesterday
in which an armed thief posed as a delivery driver
and robbed somebody for $11 million of Ethereum and Bitcoin
was Locky Groom that was targeted.
Whoa, what?
Which I had...
No way.
I didn't realize that it was him,
but absolutely terrible.
traumatic and yeah when self-custody goes wrong but i'm glad he's glad he's okay and safe wow
an armed thief posing his delivery guy finesse his way into the 4.4 million dollar miss
mission district home shared by investor locky groom yes sam altman's ex-boyfriend and another
tech investor named joshua okay so it was not locky but joshua um gary tan
posted the footage, panicked enough to delete it minutes later.
Crypto security experts are now saying what everyone thinks,
self-custody is great until someone shows up your door with a fake UPS label in a Glock.
San Francisco's tech leader about to hard pivot into vault custody, private security,
zero public flexing because this heist wasn't random.
It was a warning shot.
Very Chad, Chabutty, Rit.
Mario Knopfal.
But, anyways, very sad.
Yeah.
But glad Joshua is okay.
I was confused for a second.
That is terrible.
Anyways, thank you for tuning in today, folks.
Before we head out, I've got to tell you about 8Sleep.com.
Exceptional sleep without exception.
Fall asleep faster, sleep deeper, and wake up energized.
And I'm also going to tell you about wander.com.
Book of Wander with inspiring views, hotel great amenities,
dreamy beds, top tier cleaning, and 24-7 concierge service.
It's a vacation home but better, folks.
Thank you for taking the time to listen to the show.
Thanks for dealing with our stream issues up and down.
We sorted it out.
Never happened before.
The full interviews will be posted.
Yeah, the full interviews will be posted.
Obviously, RSS feed, YouTube, and the full Kion interview has made it sway to the timeline.
Obviously, there's a lot of debate.
We will continue covering it, but not tomorrow because we're off and not Thursday because it's Thanksgiving.
We will be back on Friday for Black Friday.
We have a fantastic lineup of a bunch of different.
entrepreneurs, e-commerce, founders, founders, brand builders.
Some of the most savage
operators.
It will be a lot of fun.
Cannot wait.
It's going to be a great time.
A lot of friends.
Have a wonderful Thanksgiving.
We are thankful for each and every one of you.
Thank you for being a part of this.
And we'll see you Friday.
Goodbye.
Cheers.
